[go: up one dir, main page]

US20210369132A1 - Intraluminal reference electrode for cardiovascular treatment apparatus - Google Patents

Intraluminal reference electrode for cardiovascular treatment apparatus Download PDF

Info

Publication number
US20210369132A1
US20210369132A1 US17/029,890 US202017029890A US2021369132A1 US 20210369132 A1 US20210369132 A1 US 20210369132A1 US 202017029890 A US202017029890 A US 202017029890A US 2021369132 A1 US2021369132 A1 US 2021369132A1
Authority
US
United States
Prior art keywords
reference electrode
end effector
connector
elongated shaft
cardiovascular tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US17/029,890
Inventor
Pieter Emmelius VAN NIEKERK
Jamie Lynn MALINARIC
Cesar Fuentes-Ortega
Henry SALAZAR
Dustin R. Tobey
Shubhayu Basu
Sean D. Thaler
Joseph R. WONG
Daniele Ghidoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosense Webster Israel Ltd
Original Assignee
Biosense Webster Israel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosense Webster Israel Ltd filed Critical Biosense Webster Israel Ltd
Priority to US17/029,890 priority Critical patent/US20210369132A1/en
Assigned to BIOSENSE WEBSTER (ISRAEL) LTD. reassignment BIOSENSE WEBSTER (ISRAEL) LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BASU, SHUBHAYU, SALAZAR, Henry, FUENTES-ORTEGA, Cesar, GHIDOLI, DANIELE, MALINARIC, JAMIE LYNN, Tobey, Dustin R., VAN NIEKERK, PIETER EMMELIUS, THALER, SEAN D., WONG, Joseph R.
Priority to CN202011069986.XA priority patent/CN113796869A/en
Priority to EP20199230.2A priority patent/EP3915501B1/en
Priority to EP20199175.9A priority patent/EP3915477B1/en
Priority to JP2020164914A priority patent/JP7512156B2/en
Priority to IL277699A priority patent/IL277699B2/en
Priority to EP24213973.1A priority patent/EP4483828A3/en
Priority to CN202011055244.1A priority patent/CN113796868A/en
Priority to IL277697A priority patent/IL277697B2/en
Priority to JP2020164921A priority patent/JP2021186647A/en
Priority to EP23163381.9A priority patent/EP4218579B1/en
Priority to EP22194803.7A priority patent/EP4159124B1/en
Priority to EP24202982.5A priority patent/EP4477171B1/en
Publication of US20210369132A1 publication Critical patent/US20210369132A1/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/279Bioelectric electrodes therefor specially adapted for particular uses
    • A61B5/28Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
    • A61B5/283Invasive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • A61B5/042
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/279Bioelectric electrodes therefor specially adapted for particular uses
    • A61B5/28Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
    • A61B5/283Invasive
    • A61B5/287Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6852Catheters
    • A61B5/6859Catheters with multiple distal splines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods
    • A61B2017/00526Methods of manufacturing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00059Material properties
    • A61B2018/00071Electrical conductivity
    • A61B2018/00077Electrical conductivity high, i.e. electrically conducting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00059Material properties
    • A61B2018/00071Electrical conductivity
    • A61B2018/00083Electrical conductivity low, i.e. electrically insulating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/0016Energy applicators arranged in a two- or three dimensional array
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00172Connectors and adapters therefor
    • A61B2018/00178Electrical connectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/00267Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577Ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00839Bioelectrical parameters, e.g. ECG, EEG
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00875Resistance or impedance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/1407Loop
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1467Probes or electrodes therefor using more than two electrodes on a single probe
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/16Indifferent or passive electrodes for grounding
    • A61B2018/162Indifferent or passive electrodes for grounding located on the probe body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/20Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
    • A61B2034/2046Tracking techniques
    • A61B2034/2051Electromagnetic tracking systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2218/00Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2218/001Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
    • A61B2218/002Irrigation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0209Special features of electrodes classified in A61B5/24, A61B5/25, A61B5/283, A61B5/291, A61B5/296, A61B5/053

Definitions

  • Cardiac arrhythmias such as atrial fibrillation, occur when regions of cardiac tissue abnormally conduct electric signals. Procedures for treating arrhythmia include surgically disrupting the conducting pathway for such signals.
  • energy e.g., radiofrequency (RF) energy and/or electroporation
  • RF radiofrequency
  • the ablation process may provide a barrier to unwanted electrical pathways by creating electrically insulative lesions or scar tissue.
  • a catheter with one or more electrodes can be used to provide ablation within the cardiovascular system.
  • the catheter can be inserted into a major vein or artery (e.g., the femoral artery) and then advanced to position the electrodes within the heart or in a cardiovascular structure adjacent to the heart (e.g., the pulmonary vein).
  • the electrodes can be placed in contact with cardiac tissue or other vascular tissue and then electrically activated to ablate the contacted tissue.
  • the electrodes can be bipolar.
  • a monopolar electrode may be used in conjunction with a ground pad that is in contact with the patient.
  • ablation catheters are described in U.S. Pub. No. 2013/0030426, entitled “Integrated Ablation System using Catheter with Multiple Irrigation Lumens,” published Jan. 31, 2013; U.S. Pat. No. 10,660,700 entitled “Irrigated Balloon Catheter with Flexible Circuit Electrode Assembly,” issued May 26, 2020; U.S. Pub. No. 2018/0071017, entitled “Ablation Catheter with a Flexible Printed Circuit Board,” published Mar. 15, 2018; U.S. Pub. No. 2018/0056038, entitled “Catheter with Bipole Electrode Spacer and Related Methods,” published Mar. 1, 2018; U.S. Pub. No.
  • EP mapping may include the use of sensing electrodes on a catheter (e.g., the same catheter that is used to perform the ablation).
  • the sensing electrodes can be the same or different electrodes as those used to perform ablation.
  • the sensing electrodes can monitor electrical signals within the cardiovascular system to pinpoint the location of aberrant conductive tissue sites that are responsible for the arrhythmia. Examples of an EP mapping system are described in U.S. Pat. No. 5,738,096, entitled “Cardiac Electromechanics,” issued Apr. 14, 1998 of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference. Examples of EP mapping catheters are described in U.S.
  • EP mapping procedures may include the use of a reference electrode on a mapping catheter to sense electrical potentials in fluids near tissue.
  • a reference electrode is described in U.S. Pub. No. 2020/0038101, entitled “Unipolar reference electrode for electrophysiology mapping catheter,” published Feb. 6, 2020, of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • some catheter ablation procedures may be performed using an image guided surgery (IGS) system.
  • IGS image guided surgery
  • the IGS system may enable the physician to visually track the location of the catheter within the patient, in relation to images of anatomical structures within the patient, in real time.
  • Some systems may provide a combination of EP mapping and IGS functionalities, including the CARTO system by Biosense Webster, Inc. of Irvine, Calif. Examples of catheters that are configured for use with an IGS system are disclosed in U.S. Pat. No. 9,480,416, entitled “Signal Transmission Using Catheter Braid Wires,” issued Nov. 1, 2016, of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference; and various other references that are cited herein and attached in the Appendix in the priority U.S. Provisional Patent Application 62/052,553.
  • Examples presented herein generally include systems and methods which can contact electrodes to cardiac tissue while sensing electrical potential from fluids near the tissue.
  • the electrodes in contact with the tissue can be carried by an end effector.
  • the end effector sensors can be configured to ablate and/or sense electrical potentials from the cardiac tissue in which they are in contact.
  • a reference electrode can be insulated by a shaft connected to the end effector so that the reference electrode can sense the electrical potentials from the fluids near the tissue while being prevented, by the shaft geometry, from contacting the cardiac tissue.
  • the reference electrode can further serve as an extension of an irrigation tube positioned to irrigate the treatment area.
  • An example apparatus can include an elongated shaft, an end effector, and a reference electrode.
  • a proximal portion of the elongated shaft can be manipulated to position a distal portion of the elongated shaft into a heart of a patient.
  • the end effector can be disposed near the distal portion of the elongated shaft and can include spines each carrying at least one spine electrode.
  • the spine electrodes can be positioned and otherwise configured to contact cardiovascular tissue.
  • the spine electrodes can further be configured to receive electrical potentials from the tissue.
  • the reference electrode can include a tubular, electrically conductive inner surface and an outer surface. The reference electrode can be disposed in the elongated shaft such that the electrode does not protrude beyond the elongated shaft.
  • the inner surface can receive electrical potentials from fluids so that the electrical potentials received by the reference electrode act as a referential signal for the electrical potentials of tissue received by the electrodes carried by the spines.
  • the outer surface of the reference electrode can be substantially electrically isolated from the electrical potentials of the fluids by an electrically insulating cover.
  • the apparatus can further include a connector joining the elongated shaft to the end effector.
  • the connector can include the electrically insulating cover which electrically isolates the outer surface of the reference electrode.
  • the reference electrode can have a distal end approximately coplanar or coaxial to a distal end of the connector.
  • the connector can be a distal extension of the shaft such that the reference electrode is approximately coplanar or coaxial with a distal end of the shaft by virtue of being approximately coplanar or coaxial with the distal end of the connector.
  • the connector can be capable of contacting the cardiovascular tissue while the spine electrodes are in contact with the cardiovascular tissue and while the reference electrode is electrically insulated, by the connector, from the cardiovascular tissue.
  • the end effector can have an unconstrained configuration aligned with a longitudinal axis of the apparatus and a particular geometry in the unconstrained configuration.
  • the connector can include a tubular outer surface with a diameter measured orthogonal to the longitudinal axis.
  • the end effector can have a height measured orthogonal to the longitudinal axis and a width measured orthogonal to the height and longitudinal axis when the end effector is in the unconstrained configuration.
  • the height of the end effector can measure approximately equal to or less than the diameter of the tubular outer surface of the connector, and the width of the end effector can measure greater than the diameter of the tubular outer surface of the connector.
  • the apparatus can further include an irrigation tube in fluidic communication with the inner surface of the reference electrode.
  • the reference electrode can function as a distal extension of the irrigation tube.
  • the irrigation tube can be positioned within a lumen of the reference electrode and/or around the outer surface of the reference electrode.
  • the outer surface of the reference electrode can be electrically insulated by a portion of the irrigation tube positioned over the outer surface of the reference electrode.
  • the spine electrodes can be positioned to preferably be distributed in a radially asymmetric pattern on the cardiovascular tissue in relation to the reference electrode's position when the plurality of spine electrodes are in contact with the cardiovascular tissue.
  • the spine electrodes can be positioned to form a rectangular grid when the plurality of spine electrodes are contact with the cardiovascular tissue.
  • the end effector can have a particular geometry including three loop members.
  • Each of the loop members can include at least one of the spines (which each carry electrode positioned to contact tissue).
  • the loop members can be joined at a common distal vertex. When the end effector is unconstrained, the distal vertex is aligned with a longitudinal axis defined by the elongated shaft.
  • Each of the three loop members can include a respective pair of ends affixed to the distal portion of the elongated shaft. The end effector can deflect away from the unconstrained configuration at an angle relative to the longitudinal axis to position the spine electrodes against a planar surface.
  • the connector can secure each of the respective pair of ends of the loop members to the distal portion of the elongated shaft.
  • the end effector can deflect at an angle relative to the longitudinal axis to position the spine electrodes against a planar area of the cardiovascular tissue.
  • the spine electrodes can receive electrical potentials from the cardiovascular tissue when in contact with the cardiovascular tissue.
  • the spine electrodes can ablate when in contact with the cardiovascular tissue.
  • An example method can include one or more of the following steps presented in no particular order.
  • An end effector can be assembled such that the end effector carries at least one spine electrode thereon that is configured to contact cardiovascular tissue and receive electrical potentials from the tissue.
  • a reference electrode can be affixed in relation to the end effector such that a tubular inner surface of the reference electrode is configured to receive electrical potentials from fluids so that the electrical potential from the fluids act as a referential signal for the electrical potentials received by the spine electrodes.
  • An outer surface of the reference electrode can be electrically insulated such that the outer surface is electrically isolated from the electrical potentials from fluids approximate the cardiovascular tissue while the inner surface is capable of receiving the electrical potentials of the fluids.
  • the end effector and reference electrode can be affixed to a distal portion of an elongated shaft, the elongated shaft configured to be manipulated at a proximal portion of the elongated shaft to position the distal portion into a heart of a patient.
  • the method can further include joining the elongated shaft to the end effector with a connector and electrically insulating the outer surface of the reference electrode with the connector.
  • the method can further include joining the end effector with the connector and an outer surface area of the reference electrode partially exposed electrode and positioned without the possibility of touching tissue.
  • the method can further include affixing the reference electrode and the connector such that a distal end of the reference electrode and a distal end of the connector are approximately coplanar and coaxial to each other.
  • the connector can be a distal extension of the shaft such that the reference electrode is approximately coplanar or coaxial to the distal end of the shaft by virtue of being approximately coplanar or coaxial to the distal end of the connector.
  • the method can further include joining the elongated shaft to the end effector such that the connector is capable of contacting the cardiovascular tissue while the spine electrode is in contact with the cardiovascular tissue and while the reference electrode is electrically insulated, by the connector, from the cardiovascular tissue.
  • the method can further include assembling the end effector such that the end effector has an unconstrained configuration, and such that, when in the unconstrained configuration, the end effector has a height that is approximately equal to or less than a diameter of a tubular outer surface of the connector and the end effector has a width measuring greater than the diameter of the tubular outer surface of the connector, the diameter and height being measured orthogonal to a longitudinal axis defined by the elongated shaft, and the width being measured orthogonal to the longitudinal axis and direction of measurement of the height.
  • the method can further include positioning an irrigation tube within the elongated shaft such that the irrigation tube is in fluidic communication with the inner surface of the reference electrode.
  • the method can further include affixing the reference electrode to the irrigation tube such that the reference electrode is a distal extension of the irrigation tube.
  • the method can further include arranging the spine electrodes in a rectangular grid.
  • the method can further include arranging the spine electrodes in a non-rectangular grid.
  • the method can further include shaping a first loop member, a second loop member and a third loop member to each form a respective loop; coupling a respective pair of ends for each of the first loop member, the second loop member, and the third loop member to the distal portion of the elongated shaft; joining the first loop member, the second loop member, and the third loop member at a common distal vertex distal to the distal portion of the elongated shaft; and configuring the end effector to be capable of deflecting at an angle relative to a longitudinal axis defined by the elongated shaft to position the spine electrodes against a planar surface.
  • the method can further include securing each of the respective pairs of ends to the distal portion of the elongated shaft with a connector and electrically insulating the outer surface of the reference electrode with the connector.
  • the method can further include configuring the end effector to deflect at an angle relative to the longitudinal axis to position the spine electrodes against a planar area of the cardiovascular tissue.
  • Another example method can include one or more of the following steps presented in no particular order. Steps of this example method are combinable with steps of the previous example method.
  • a distal portion of the elongated shaft, and an end effector extending distally from a distal portion of the elongated shaft can be moved through a catheter to a heart.
  • the end effector can be moved from a distal end of the catheter via manipulation of a proximal portion of the elongated shaft.
  • Spine electrodes, carried by the end effector can be juxtaposed to cardiovascular tissue via manipulation of the proximal portion of the elongated shaft. While the spine electrodes are opposed to the cardiovascular tissue, electrical potentials from fluids approximate the cardiovascular tissue can be received via an inner surface of a reference electrode, an outer surface of the reference electrode being electrically insulated from the electrical potentials.
  • the method can further include contacting, to the cardiovascular tissue, while the spine electrodes are opposed (i.e., in physical contact) to the cardiovascular tissue, a connector joining the end effector to the distal portion of the elongated shaft and electrically insulating the outer surface of the reference electrode from the electrical potentials.
  • the method can further include irrigating the cardiovascular tissue through a lumen defined by the inner surface of the reference electrode.
  • the method can further include positioning the spine electrodes in a pattern on the cardiovascular tissue that is radially asymmetric in relation to the reference electrode's position.
  • the method can further include positioning the spine electrodes in a rectangular grid on the cardiovascular tissue.
  • the method can further include deflecting the end effector at an angle relative to a longitudinal axis defined by the elongated shaft to position the spine electrodes against the cardiovascular tissue.
  • the cardiovascular tissue against which the spine electrodes are positioned being can be substantially planar.
  • the method can further include receiving, while the spine electrodes are opposed to the cardiovascular tissue, electrical potentials from the cardiovascular tissue via the spine electrodes.
  • the method can further include ablating the cardiovascular tissue via the spine electrodes, while the spine electrodes are opposed to the cardiovascular tissue.
  • FIG. 1 is an illustration of a cardiovascular treatment apparatus having an end effector at a distal portion of an elongated shaft and a proximal handle at a proximal portion of the elongated shaft according to aspects of the present invention.
  • FIGS. 2A and 2B are illustrations of cross sectional views of an intermediate section and distal portion of a shaft of the apparatus in greater detail according to aspects of the present invention.
  • FIGS. 3A through 3C are various views of the end effector and distal portion of the shaft according to aspects of the present invention.
  • FIGS. 3D through 3F are illustrations of various views of the distal portion of the shaft according to aspects of the present invention.
  • FIGS. 4A through 4C are illustrations of the end effector being pressed to a planar surface according to aspects of the present invention.
  • FIGS. 5A and 5B are illustrations of cross sectional views of alternative reference electrode configurations according to aspects of the present invention.
  • FIG. 6 is an illustration of a treatment utilizing the cardiovascular treatment apparatus according to aspects of the present invention.
  • FIGS. 7A through 7F are illustrations of alternative end effectors having loop members and including an intralumenal reference electrode according to aspects of the present invention.
  • FIG. 8 is an illustration of an alternative end effector having a ray geometry and including an intralumenal reference electrode according to aspects of the present invention.
  • FIG. 9 is an illustration of another alternative end effector including an intralumenal reference electrode according to aspects of the present invention.
  • the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. More specifically, “about” or “approximately” may refer to the range of values ⁇ 10% of the recited value, e.g. “about 90%” may refer to the range of values from 81% to 99%.
  • the terms “patient,” “host,” “user,” and “subject” refer to any human or animal subject and are not intended to limit the systems or methods to human use, although use of the subject invention in a human patient represents a preferred embodiment.
  • non-transitory computer-readable media includes, but is not limited to, random access memory (RAM), read-only memory (ROM), electronically erasable programmable ROM (EEPROM), flash memory or other memory technology, compact disc ROM (CD-ROM), digital versatile disks (DVD) or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other tangible, physical medium which can be used to store computer readable information.
  • RAM random access memory
  • ROM read-only memory
  • EEPROM electronically erasable programmable ROM
  • flash memory or other memory technology
  • compact disc ROM CD-ROM
  • DVD digital versatile disks
  • magnetic cassettes magnetic tape
  • magnetic disk storage magnetic disk storage devices
  • tubular and “tube” are to be construed broadly and are not limited to a structure that is a right cylinder or strictly circumferential in cross-section or of a uniform cross-section throughout its length.
  • the tubular structure or system is generally illustrated as a substantially right cylindrical structure.
  • the tubular system may have a tapered or curved outer surface without departing from the scope of the present invention.
  • wire can include elongated solid core and hollow core structures.
  • wire can include insulated, non-insulated, individual, bundled, and integrated circuit conductors.
  • FIG. 1 illustrates an example apparatus 10 having an elongated shaft 9 , a distal electrode assembly or end effector 100 , and a deflection control handle 16 .
  • the apparatus 10 can have several design variations while including novel aspects illustrated herein.
  • the apparatus 10 is presented for illustration purposes only and is not intended to be limiting. Details of the apparatus can be understood with reference to U.S. Patent Application Ser. No. 63/031,955 to which the present application claims the benefits of priority and which is incorporated herein by reference.
  • the elongated shaft 9 has a proximal portion 12 in the shape of an elongated catheter body, an intermediate deflection section 14 , and distal portion 14 A.
  • the deflection control handle 16 is attached to the proximal end of the catheter body 12 .
  • the distal portion 14 A of the shaft is coupled to the end effector 100 via a connector tubing 46 .
  • the connector tubing 46 is considered herein to be a distal extension of the elongated shaft such that the connector tubing 46 is considered a part of the elongated shaft 9 .
  • the elongated shaft 9 forms a tubular catheter body sized and otherwise configured to traverse vasculature.
  • the proximal portion 12 of the elongated shaft 9 can be manipulated (e.g.
  • the end effector 100 has a plurality of loop members 1 , 2 , 3 that overlap at a common distal vertex 50 .
  • the loop members 1 , 2 , 3 can be joined at the distal vertex 50 by a mechanical linkage.
  • the end effector 100 is illustrated in an unconstrained configuration.
  • the proximal portion 12 , intermediate section 14 , distal portion 14 A, and end effector 100 are generally aligned along a longitudinal axis A-A.
  • the elongated shaft 9 can define the longitudinal axis A-A of the apparatus 10 .
  • the intermediate section 14 can be configured to bend to deflect the distal portion 14 A and end effector 100 from the longitudinal axis A-A similar to as described in U.S. Pat. No. 9,820,664 (see FIGS. 6 and 7) incorporated by reference herein in its entirety and attached in the appendix hereto. Details of the apparatus can be understood with reference to U.S. Patent Application Ser. No. 63/031,955.
  • the end effector 100 can be collapsed (compressed toward the longitudinal axis A-A) to fit within a guiding sheath or catheter (not illustrated).
  • the shaft 9 can be pushed distally to move the end effector 100 distally through the guiding sheath.
  • the end effector 100 can be moved to exit a distal end of the guiding sheath via manipulation of the shaft 9 and/or control handle 16 .
  • An example of a suitable guiding sheath for this purpose is the Preface Braided Guiding Sheath, commercially available from Biosense Webster, Inc. (Irvine, Calif., USA).
  • the end effector 100 has first, second and third loop members 1 , 2 , and 3 .
  • Each loop member 1 , 2 , 3 has two spines 1 A, 1 B, 2 A, 2 B, 3 A, 3 B and a connector 1 C, 2 C, 3 C that connects the two spines of the respective loop member 1 , 2 , 3 .
  • Spines 1 A, 1 B of the first loop member 1 are connected by a first connector 1 C; spines 2 A, 2 B of the second loop member 2 are connected by a second connector 2 C; and spines 3 A, 3 B of the third loop member 3 are connected by a third connector 3 C.
  • Each loop member 1 , 2 , 3 further has a respective pair of ends affixed to the distal portion 14 A of the elongated shaft 9 (e.g. affixed to the connector 46 which is an extension of the distal portion 14 A of the elongated shaft 9 ).
  • the spines 1 A, 1 B, 2 A, 2 B, 3 A, 3 B in the respective pair of spines can be substantially parallel to each other along a majority of their respective lengths when the end effector 100 is expanded in an unconstrained configuration as illustrated in FIG. 1 .
  • all spines in the end effector are parallel to each other along the majority of their respective lengths when the end effector 100 is in the unconstrained configuration. Even when all spines are parallel, the spines are not necessarily all coplanar. Details of the apparatus can be understood with reference to U.S. Patent Application Ser. No. 63/031,955.
  • Each spine 1 A, 1 B, 2 A, 2 B, 3 A or 3 B can have a length ranging between about 5 and 50 mm, preferably between about 10 and 35 mm, and more preferably about 28 mm.
  • the parallel portions of each spine 1 A, 1 B, 2 A, 2 B, 3 A, 3 B can be spaced apart from each other by a distance ranging between about 1 mm and 20 mm, preferably between about 2 and 10 mm, and more preferably about 4 mm.
  • Each spine 1 A, 1 A, 1 B, 2 A, 2 B, 3 A, 3 B preferably carries at least eight electrodes per spine member.
  • the end effector preferably includes six spines as illustrated. With eight electrodes on six spines, the end effector 100 includes forty-eight electrodes.
  • the spine electrodes 37 can be positioned and otherwise configured to contact cardiovascular tissue.
  • the spine electrodes 37 can be configured to receive electrical potentials from tissue that they are in contact with and/or ablate the tissue.
  • FIG. 1 is illustrated as including a distal electrode 38 D and a proximal electrode 38 P positioned near the distal portion 14 A of the shaft 9 .
  • the electrodes 38 D and 38 P can be configured to cooperate (e.g. by masking of a portion of one electrode and masking a different portion on the other electrode) to define a referential electrode (an electrode that is not in contact with tissues).
  • the apparatus 10 can include a reference electrode 5 positioned within the connector tubing 46 so that is it is prevented from contacting tissue by the connector tubing 46 .
  • the reference electrode 5 can be used in addition to, or in place of one or both of the distal electrode 38 D and the proximal electrode 38 P illustrated in FIG. 1 . Due to the likelihood of the electrodes 38 D and 38 P coming into contact with tissues, it is preferable that reference electrode 5 is utilized by itself.
  • a reference potential from blood near the tissue at which a tissue potential is being picked up it can be desirable to obtain a reference potential from blood near the tissue at which a tissue potential is being picked up.
  • the reference electrode can be in direct contact with the blood and/or be in electrical communication with the blood via other fluids such as irrigation fluid.
  • the second (reference) electrode can be configured such that it is prevented from contacting tissue while maintaining electrical communication with blood.
  • the second (reference) electrode By having the second (reference) electrode avoid contact with tissue, the second (reference) electrode may avoid pickup of local tissue potentials that might otherwise compromise the reliability of the sensed reference potential.
  • This configuration can provide benefits similar to those obtained using bipolar EP mapping devices and techniques, such as reduced noise and reduced far field signals, due to the location of the reference electrode being in the same heart chamber as tissue-contacting electrodes; while still maintaining features of a unipolar signal.
  • each of the reference electrodes 38 D, 38 P on the outside shaft 9 may contact tissue while the opposite side of each of the shaft reference electrodes 38 D, 38 P faces away from the tissue.
  • the electrodes 38 D, 38 P can be masked with an electrical insulator on opposite sides such that when an unmasked side of one of the electrodes is against tissue, an unmasked side of the other electrode is facing away from the tissue; meaning, if one of the shaft reference electrodes 38 D, 38 P is in electrical contact with tissue, the other of the shaft electrodes 38 D, 38 P is insulated from the tissue by an electrically insulating mask.
  • Examples presented herein include a reference electrode 5 that has an electrically insulated outer surface such that electrically conductive portions of the reference electrode 5 are prevented from ever coming into contact with tissue. This eliminates the need for two electrodes (e.g. aforementioned shaft electrodes 38 D, 38 P) thereby reducing wires and bulk.
  • the end effector 100 can be joined to the connector tubing 46 such that an outer surface area of the reference electrode 5 is partially exposed electrically and the exposed outer surface is positioned to prohibit the possibility that the exposed outer surface touches tissue during treatment.
  • One or more impedance sensing electrodes 38 R can be configured to allow for location sensing via impedance location sensing technique, as described in U.S. Pat. Nos. 5,944,022; 5,983,126; and 6,445,864, for each of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • FIGS. 2A and 2B illustrate the intermediate section 14 and distal portion 14 A of the shaft 9 of the apparatus in greater detail.
  • FIG. 2A is a cross-sectional view, along the longitudinal axis A-A, of the elongated shaft 9 at the interface between the proximal portion 12 and intermediate section 14 .
  • FIG. 2B is a cross-sectional view of the intermediate section 14 orthogonal to the longitudinal axis A-A.
  • the catheter body 12 can be an elongated tubular construction having a single axial passage or central lumen 18 .
  • the central lumen 18 can be sized to allow an irrigation tube 15 to pass therethrough.
  • the catheter body 12 is flexible, i.e., bendable, but substantially non-compressible along its length.
  • the catheter body 12 can be of any suitable construction and made of any suitable material.
  • the catheter body 12 has an outer wall 20 made of polyurethane or PEBAX.
  • the outer wall 20 may include an imbedded braided mesh of stainless steel or the like to increase torsional stiffness of the catheter body 12 so that, when the control handle 16 is rotated, the intermediate section 14 will rotate in a corresponding manner.
  • the outer diameter of the catheter body 12 is preferably no more than about 8 French, more preferably about 7 French.
  • the thickness of the outer wall 20 is thin enough so that the central lumen 18 can accommodate at least one puller wire, one or more lead wires, and any other desired wires, cables or tubes (e.g. irrigation tube 15 ).
  • the inner surface of the outer wall 20 is lined with a stiffening tube 22 to provide improved torsional stability.
  • the outer wall 20 has an outer diameter of from about 0.090 inch to about 0.094 inch (from about 2.3 mm to about 2.4 mm) and an inner diameter of from about 0.061 inch to about 0.065 inch (from about 1.5 mm to about 1.7 mm).
  • the intermediate section 14 can include a shorter section of tubing 19 having multiple lumens, for example, four off-axis lumens 31 , 32 , 33 , 34 and a central lumen 35 .
  • the first lumen 31 carries a plurality of lead wires 40 S for ring electrodes 37 carried on the spines 1 A, 1 B, 2 A, 2 B, 3 A, 3 B.
  • the second lumen 32 carries a first puller wire 24 .
  • the third lumen 33 carries a cable 36 for an electromagnetic position sensor 42 and lead wires 40 D and 40 P for distal and proximal ring electrodes 38 D and 38 P carried on the catheter proximally of the end effector 100 and/or the reference electrode 5 within the tubing 46 .
  • Electromagnetic location sensing technique is described in U.S. Pat. Nos. 5,391,199; 5,443,489; 5,558,091; 6,172,499; 6,590,963; and 6,788,967, for each of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • the magnetic location sensor 42 can be utilized with impedance sensing electrode 38 R in a hybrid magnetic and impedance position sensing technique known as ACL described in U.S. Pat. Nos. 7,536,218; 7,756,567; 7,848,787; 7,869,865; and 8,456,182, for each of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • the fourth lumen 34 (for example, diametrically opposite of the second lumen 32 as illustrated) carries a second puller wire 26 .
  • the fifth, central lumen 35 carries the irrigation tube 15 .
  • the tubing 19 is made of a suitable non-toxic material that is preferably more flexible than the catheter body 12 .
  • One suitable material for the tubing 19 is braided polyurethane, i.e., polyurethane with an embedded mesh of braided stainless steel or the like. The size of each lumen is sufficient to house the lead wires, puller wires, the cable and any other components.
  • the useful length of the catheter shaft 9 i.e., that portion of the apparatus 10 that can be inserted into the body excluding the end effector 100 , can vary as desired. Preferably the useful length ranges from about 110 cm to about 120 cm.
  • the length of the intermediate section 14 is a relatively smaller portion of the useful length, and preferably ranges from about 3.5 cm to about 10 cm, more preferably from about 5 cm to about 6.5 cm.
  • Catheter body proximal portion 12 can be attached to the intermediate section 14 similar to as shown and described in FIGS. 2A and 2B of U.S. Pat. No. 9,820,664, of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • a spacer (not shown) can be located within the catheter body 12 between the distal end of the stiffening tube (if provided) and the proximal end of the intermediate section 14 .
  • the spacer can provide a transition in flexibility at the junction of the catheter body 12 and intermediate section 14 , which can allow this junction to bend smoothly without folding or kinking.
  • a catheter having such a spacer is described in U.S. Pat. No. 5,964,757, of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • the distal portion 14 A of the shaft 9 can be substantially contiguous with the intermediate section 14 such that the intermediate section comprises the distal portion 14 A; the distal portion being distinguished from the intermediate section 14 by the positioning of one or more (optional) ring electrodes 38 R. As referred to herein, the distal portion 14 A of the shaft 9 can therefore correspond to a distal portion of the intermediate section 14 .
  • the connector tubing 46 can also be considered a distal extension of the shaft 9 so that it is understood that the connector tubing 46 is included in the distal portion 14 A of the shaft.
  • FIGS. 3A through 3C illustrate the end effector and distal portion of the shaft 9 (connector tubing 46 ) in various orientations where the connector tubing is illustrated as translucent and all components within the connector tubing are made invisible with the exception of the reference electrode 5 and the irrigation tube 15 for the purposes of illustration.
  • the connector tubing 46 can further house ends of support frames which extend through the loop members 1 , 2 , 3 to secure the loop members 1 , 2 , 3 to the shaft 9 similar to the apparatus described and illustrated in U.S. Patent Application Ser. No. 63/031,955.
  • the connector tubing 46 can further house electrical conductors 36 , 40 D, 40 P, 40 S such as those illustrated in FIGS. 2A and 2B .
  • FIGS. 3D through 3F illustrate the connector tubing in various orientations with the end effector 100 made invisible for the purpose of illustration.
  • FIGS. 3A through 3F A Cartesian x, y, z axis is illustrated in each of the FIGS. 3A through 3F to illustrate relative orientations for each of the illustrations.
  • the reference electrode 5 can include a tubular inner surface 5 B and a tubular outer surface 5 C.
  • the inner tubular surface 5 B can be electrically conductive.
  • the inner surface 5 B can be positioned and otherwise configured so that fluids near cardiovascular tissue (e.g. blood and/or irrigation fluid) are in contact with the inner surface 5 B when the spine electrodes 37 are in contact with cardiovascular tissue.
  • the inner surface 5 B can receive electrical potentials from these fluids so that the electrical potentials received by the reference electrode act as a referential signal for the electrical potentials of the electrodes 37 carried by the spines 1 A, 1 B, 2 A, 2 B, 3 A, 3 B.
  • the reference electrode 5 can be disposed in the elongated shaft 9 (being disposed in the connector 46 which is a distal extension of the shaft 9 ) such that the electrode does not protrude beyond the elongated shaft 9 .
  • the outer surface 5 C of the reference electrode 5 can be substantially electrically isolated from the electrical potentials of the fluids.
  • the connector 46 of the shaft 9 can serve as an insulating cover which electrically isolates the outer surface 5 C.
  • the reference electrode 5 can have a distal end 5 A that is approximately coaxial or coplanar with a distal end 46 A of the connector 46 (which corresponds to a distal end of the shaft 9 ).
  • coplanar as used in relation to the reference electrode distal end 5 A and the distal end 46 A means that a plane may intersect both 5 A and 46 A so that both ends ( 5 A and 46 A) are on the same plane.
  • a virtual plane (not shown) intersects surface 5 C and 46 A orthogonally so that both ends 5 A and 46 A are on the same plane.
  • coaxial indicates that the longitudinal axis of connector 46 and the longitudinal axis of the reference electrode 5 are coincident with each other.
  • the connector 46 can be capable of contacting the cardiovascular tissue while the spine electrodes are in contact with the cardiovascular tissue and while the reference electrode 5 is electrically insulated, by the connector, from the cardiovascular tissue as illustrated in greater detail in FIG. 4C .
  • the irrigation tube can be in fluidic communication with the inner surface 5 B of the reference electrode 5 . Fluids can flow through the irrigation tube and out of the shaft 9 through the reference electrode 5 so that the reference electrode 5 serves as a distal extension of the irrigation tube 15 .
  • the end effector 100 can have an unconstrained configuration aligned with a longitudinal axis A-A of the apparatus 10 and a flattened or paddle shaped geometry in the unconstrained configuration.
  • the end effector 100 can have a height H and a width W measured as indicated in FIGS. 3A and 3B , the height H being significantly smaller than the width W.
  • the height H of the end effector 100 can be about equal to, or smaller than, a diameter D 1 of a tubular outer surface of the connector 46 , where the diameter D 1 is measured as indicated in FIG. 3A .
  • the width W of the end effector 100 can be substantially greater than the diameter D 1 of the connector 46 .
  • the end effector can have a length L measured as indicated in FIG. 3A that is greater still than the width W.
  • the spine electrodes 37 are all positioned in a distal direction in relation to the reference electrode 5 .
  • the spine electrodes 37 and references electrode 5 can roughly maintain their relative positions to each other compared to the unconstrained configuration. This results in the spine electrodes 37 being positioned to preferably be distributed in a radially asymmetric pattern on the cardiovascular tissue in relation to the reference electrode's position when the plurality of spine electrodes 37 are in contact with the cardiovascular tissue.
  • the reference electrode 5 is positioned to one side of the collection of spine electrodes 37 when the electrodes 5 , 37 are in operation during a treatment. This in contrast to other end effector geometries, such as illustrated in FIG.
  • Paddle shaped end effectors such as illustrated in FIGS. 7A through 7F also include spine electrodes positioned to be distributed in a radially asymmetric pattern on tissue in relation to the reference electrode's position.
  • the spine electrodes 37 can be positioned to form a rectangular grid when the spine electrodes 37 are contact with the cardiovascular tissue. Alternatively, the spine electrodes 37 can be positioned to form a non-rectangular grid; e.g. a circular, triangular, or other such shape.
  • the irrigation tube 15 can be positioned within a lumen of the reference 5 electrode.
  • the apparatus 10 can further include an irrigation tube cover 45 to act as a fluid impermeable seal between the reference electrode 5 and the irrigation tube 15 .
  • the distal end 5 A of the electrode 5 is approximately co-planar with the distal end 46 A of the connector 46 or even recessed ( FIG. 3E ) so that the electrode 5 does not protrude from the shaft 9 (e.g., FIG. 1 ).
  • An insulating material 51 can be provided between the outer surface 5 C of the electrode 5 and the inside surface 46 B of connector 46 .
  • material 51 can be a polymer such as for example, polyurethane. Configured as such, insulating material 51 insulates the outer surface 5 C of the electrode 5 to prevent the outer surface 5 C from coming into electrical contact with tissue during use.
  • inner surface 5 C of reference electrode 5 is able to have electrical and physical contact with the biological fluid in the organ (e.g., blood) in order to receive or record the electrical signals propagated in the fluid.
  • irrigation line 15 can also work in reverse, by aspirating or sucking blood from the organ into the irrigation line 15 . This allows for the reference electrode 5 to receive or sense electrical signals (via wiring 5 D or electrical trace) in the blood significantly better because the blood is pulled into irrigation tube 15 allowing immersion of the conductive inner surface 5 C with the blood pulled into irrigation tube 15 .
  • the connector 46 can include a collar 41 forming the outer surface 46 A of the connector 46 and an insert 43 positioned in the collar 41 .
  • the insert 43 can include openings 44 shaped to receive ends of the loop members 1 , 2 , 3 and a central lumen 48 sized to house the reference electrode 45 .
  • a polymer can be flowed into the collar 41 and insert 43 to help secure the loop members 1 , 2 , 3 and reference electrode 5 in the connector 46 .
  • FIGS. 4A through 4C are illustrations of the end effector 100 being pressed to a surface S.
  • the end effector 100 can deflect at an angle ⁇ relative to the longitudinal axis A-A to position the spine electrodes 37 to the surface S.
  • the surface S is illustrated as planar; however, the surface can be curved. For instance, the surface S can have curvature consistent with intracardiac tissue surfaces.
  • FIG. 4A illustrates the end effector 100 having a portion of spine electrodes 37 pressed to the surface S and another portion of the spine electrodes 37 above the surface S, not in contact with the surface S.
  • FIG. 4B illustrates the connector 46 positioned above the surface S with all spine electrodes 37 in contact with the surface.
  • the end effector 100 is deflected an angle ⁇ relative to the longitudinal axis A-A that is nearly 90°.
  • the reference electrode 5 may come into contact with the surface S. If the reference electrode 5 were to make electrical contact with the surface S, it can reduce the effectiveness of the reference electrode's ability to sense electrical potentials that can serve as reference electrical potentials. In other words, were the reference electrode 5 to come into electrical contact with tissue, it may not function as a reliable reference electrode.
  • Positioning the reference electrode 5 so that it does not protrude from the connector 46 of the shaft 9 prevents the reference electrode 5 from contacting the surface S even when the end effector 100 is deflected at an angle of about 90° from the longitudinal axis A-A of the shaft 9 .
  • FIG. 4C illustrates the connector 46 in contact with the surface S with all spine electrodes 37 in contact with the surface S.
  • the end effector 100 is deflected at an acute angle ⁇ relative to the longitudinal axis A-A.
  • the reference electrode 5 Having the connector 46 very near to the surface S and at a non-zero angle to the surface S, were the reference electrode 5 positioned such that it protruded from the shaft 9 , depending on the length of protrusion and the angle ⁇ , the reference electrode 5 may come into contact with the surface S.
  • Positioning the reference electrode 5 so that it does not protrude from the connector 46 of the shaft 9 prevents the reference electrode 5 from contacting the surface S even when the connector 46 is in contact with the surface S and angled toward the surface S.
  • FIGS. 5A and 5B are illustrations of an alternative reference electrode configuration.
  • the figures include a z axis to provide orientation relative to FIGS. 3A through 3F .
  • FIG. 5A is an illustration of a cross section of an alternative reference electrode configuration. Only the connector 46 , reference electrode 5 , and irrigation tube 5 are illustrated for the purposes of illustration.
  • the apparatus 10 can include additional components not illustrated such as conductors and mechanical connection to the end effector 100 described elsewhere herein, including the Appendix.
  • the irrigation tube 15 can be positioned around the outer surface 5 C of the reference electrode 5 . The transition from the irrigation tube 15 to the reference electrode 5 can be sealed to cause the reference electrode 5 to be an extension of the irrigation tube 15 .
  • the outer surface 5 C of the reference electrode 5 can be electrically insulated by a portion of the irrigation tube 15 positioned over the outer surface 5 C of the reference electrode 5 .
  • the irrigation tube 15 and reference electrode 5 can protrude from the elongated shaft so that the irrigation tube 15 prevents the outer surface 5 C of the reference electrode 5 from coming into contact with tissue.
  • the distal end 5 A of the reference electrode 5 can be positioned in the irrigation tube 15 so that the reference electrode 5 does not protrude from the irrigation tube 15 .
  • FIG. 5B is an illustration of a cross section of another alternative reference electrode configuration.
  • the reference electrode does not serve as an extension to the irrigation tube 15 but rather has an electrically conductive distal surface at its distal end 5 A that is configured to receive electrical potentials from fluids that act as a reference signal for the electrical potentials from the spine electrodes 37 .
  • the electrically conductive surface at the distal end 5 A of the reference electrode 5 is approximately coplanar or coaxial to the distal end 46 A of the connector 46 . Only the connector 46 and reference electrode 5 are illustrated for the purposes of illustration.
  • the apparatus 10 can include additional components not illustrated such as conductors and mechanical connection to the end effector 100 described elsewhere herein, including in the Appendix.
  • FIG. 6 is an illustration of an exemplary medical procedure and associated components of a cardiac electrophysiology (EP) mapping catheter system that may utilize the apparatus 10 (also referred to as a catheter assembly).
  • a physician PH is illustrated grasping the handle 16 of the apparatus, with the end effector 100 (not shown in FIG. 6 ) disposed in a patient PA to perform EP mapping in or near the heart H of the patient PA.
  • the apparatus 10 is coupled with a guidance and drive system 110 via a cable 130 .
  • the apparatus 10 can optionally be coupled with a fluid source 142 via a fluid conduit 140 .
  • a set of field generators 120 are positioned underneath the patient PA and are coupled with guidance and drive system 110 via another cable 122 . Field generators 120 are also optional.
  • the guidance and drive system 110 can include a console 112 and a display 118 .
  • the console 112 can include a first driver module 114 and a second driver module 116 .
  • the first driver module 114 can be coupled with the apparatus via a cable 130 .
  • the first driver module 114 is operable to receive EP mapping signals obtained via spine electrodes 37 of end effector 100 .
  • the console 112 can include a processor (not shown) that processes such EP mapping signals and thereby provides EP mapping.
  • the first driver module 114 may be operable to provide RF power to the spine electrodes 37 of end effector 100 to thereby ablate tissue.
  • the first driver module 114 is also operable to receive position indicative signals from a position sensor in end effector 100 .
  • the processor of console 112 is also operable to process the position indicative signals from the position sensor to thereby determine the position of the end effector 100 within the patient PA.
  • the guidance and drive system 110 can further include non-transitory computer readable medium with instructions thereon to case the drive system 110 to perform functionality described herein and/or as are known related to use of similar equipment.
  • the non-transitory computer readable memory can be in communication with the first driver module 114 (e.g. by virtue of being in communication with a processor of the first driver module 114 and/or the processor of the console 112 ).
  • the non-transitory computer readable medium can include instructions thereon that when executed by the first driver module 114 cause the first driver module 114 to receive EP mapping signals from the spine electrodes 37 and a reference signal from the reference electrode 5 .
  • the second driver module 116 is coupled with field generators 120 via a cable 122 .
  • the second driver module 116 is operable to activate field generators 120 to generate an alternating magnetic field around the heart H of the patient PA.
  • the field generators 120 may include coils that generate alternating magnetic fields in a predetermined working volume that contains the heart H.
  • Some versions of the apparatus 10 include a position sense near or within the end effector 100 that is operable to generate signals that are indicative of the position and orientation of end effector 100 within the patient PA.
  • Each position sensor may include a wire coil or a plurality of wire coils (e.g., three orthogonal coils) that are configured to generate electrical signals in response to the presence of an alternating electromagnetic field generated by field generators 120 .
  • Other components and techniques that may be used to generate real-time position data associated with end effector 100 may include wireless triangulation, acoustic tracking, optical tracking, inertial tracking, and the like.
  • position sensing may be provided in accordance with at least some of the teachings of U.S. Pat. No. 9,480,416, of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • apparatus 10 may lack a position sensor near the end effector 100 .
  • the display 118 is coupled with the processor of console 112 and is operable to render images of patient anatomy. Such images may be based on a set of preoperatively or intraoperatively obtained images (e.g., a CT or MRI scan, 3-D map, etc.). The views of patient anatomy provided through the display 118 may also change dynamically based on signals from the position sensor near the end effector 100 .
  • the processor of the console 112 may also drive the display 118 to superimpose the current location of end effector 100 on the images of the patient's anatomy, such as by superimposing an illuminated dot, a crosshair, a graphical representation of end effector 100 , or some other form of visual indication.
  • the fluid source 142 can include a bag containing saline or some other suitable irrigation fluid.
  • the conduit 140 can include a flexible tube that is further coupled with a pump 144 , which is operable to selectively drive fluid from the fluid source 142 to the irrigation tube 15 of the apparatus 10 .
  • the conduit 140 , fluid source 142 , and pump 144 are omitted entirely.
  • FIGS. 7A through 7F are illustrations of alternative end effectors 100 a - f having loop members and including an intralumenal reference electrode 5 described elsewhere herein.
  • the end effectors include a reference electrode that does not protrude from the shaft 9 and therefore is not visible in the views of the figures.
  • the end effectors can otherwise be configured similarly to the end effectors illustrated in U.S. Pat. No. 9,820,664 (see FIGS. 8A through 8F), U.S. Pub. No. 2020/0038101, and U.S. Pub. No. 2020/0038101 (see FIGS. 10 through 15), for each of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • FIG. 8 is an illustration of an alternative end effector 100 g having a ray geometry and including an intralumenal reference electrode according to aspects of the present invention.
  • the end effector includes a reference electrode 5 that does not extend beyond the shaft 9 .
  • the end effector can otherwise be configured similarly to the end effectors illustrated in U.S. Pat. No. 9,907,480 (see FIG. 5), U.S. Pub. No. 2018/0056038 (see FIG. 5), and U.S. Pub. No. 2020/0038101 (see FIGS. 2 through 7, 19, and 20).
  • reference electrode as described and illustrated herein can be utilized with an end effector having a basket configuration whereby each of the spines expand outward and converges towards a distal end is within the scope of the invention.
  • basket configuration is shown exemplarily in U.S. Pat. No. 10,575,743B2, which is incorporated by reference herein.
  • FIG. 9 is an illustration of another alternative end effector 100 h including an intralumenal reference electrode according to aspects of the present invention.
  • the end effectors include a reference electrode that does not protrude from the shaft 9 and therefore is not visible in the views of the figures.
  • the end effector can otherwise be configured similarly to the end effectors illustrated in U.S. Pat. No. 9,820,664 (see FIGS. 5A through 7) and U.S. Pub. No. 2020/0038101 (see FIG. 16).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plasma & Fusion (AREA)
  • Otolaryngology (AREA)
  • Physiology (AREA)
  • Surgical Instruments (AREA)

Abstract

Examples presented herein generally include systems and methods which can contact electrodes to cardiac tissue while sensing electrical potential from fluids near the tissue. The electrodes in contact with the tissue can be carried by an end effector and can be used to sense and/or ablate the tissue they contact. A reference electrode can be insulated by a shaft connected to the end effector so that the reference electrode can sense the electrical potentials from the fluids near the tissue while being prevented, by the shaft geometry, from contacting the cardiac tissue. In some examples, the reference electrode can be tubular, having an inner surface that is configured to contact and sense electrical potentials from the fluids and an electrically insulated outer surface. Configured as such, the reference electrode can serve as an extension of an irrigation tube extending through the shaft.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefits of priority under the Paris Convention as well as 35 USC §§ 119 and 120 to prior filed U.S. Provisional Patent Application Ser. No. 63/052,553 (Attorney Docket No. 253757.000040), titled as “INTRALUMINAL REFERENCE ELECTRODE FOR CARDIOVASCULAR TREATMENT APPARATUS” and filed on Jul. 16, 2020 and U.S. Provisional Patent Application Ser. No. 63/031,955 (Attorney Docket No. 253757.000039), titled as “ELECTRODE APPARATUS FOR DIAGNOSIS OF ARRHYTHMIAS” and filed on May 29, 2020, which priority applications are hereby incorporated by reference as set forth in full herein.
  • BACKGROUND
  • Cardiac arrhythmias, such as atrial fibrillation, occur when regions of cardiac tissue abnormally conduct electric signals. Procedures for treating arrhythmia include surgically disrupting the conducting pathway for such signals. By selectively ablating cardiac tissue by application of energy (e.g., radiofrequency (RF) energy and/or electroporation), it may be possible to cease or modify the propagation of unwanted electrical signals from one portion of the heart to another. The ablation process may provide a barrier to unwanted electrical pathways by creating electrically insulative lesions or scar tissue.
  • In some procedures, a catheter with one or more electrodes can be used to provide ablation within the cardiovascular system. The catheter can be inserted into a major vein or artery (e.g., the femoral artery) and then advanced to position the electrodes within the heart or in a cardiovascular structure adjacent to the heart (e.g., the pulmonary vein). The electrodes can be placed in contact with cardiac tissue or other vascular tissue and then electrically activated to ablate the contacted tissue. In some cases, the electrodes can be bipolar. In some other cases, a monopolar electrode may be used in conjunction with a ground pad that is in contact with the patient.
  • Examples of ablation catheters are described in U.S. Pub. No. 2013/0030426, entitled “Integrated Ablation System using Catheter with Multiple Irrigation Lumens,” published Jan. 31, 2013; U.S. Pat. No. 10,660,700 entitled “Irrigated Balloon Catheter with Flexible Circuit Electrode Assembly,” issued May 26, 2020; U.S. Pub. No. 2018/0071017, entitled “Ablation Catheter with a Flexible Printed Circuit Board,” published Mar. 15, 2018; U.S. Pub. No. 2018/0056038, entitled “Catheter with Bipole Electrode Spacer and Related Methods,” published Mar. 1, 2018; U.S. Pub. No. 2018/0036078, entitled “Catheter with Soft Distal Tip for Mapping and Ablating Tubular Region,” published Feb. 8, 2018; U.S. Pat. No. 8,956,353, entitled “Electrode Irrigation Using Micro-Jets,” issued Feb. 17, 2015; and U.S. Pat. No. 9,801,585, entitled “Electrocardiogram Noise Reduction,” issued Oct. 31, 2017, for each of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • Some catheter ablation procedures may be performed using electrophysiology (EP) mapping. Such EP mapping may include the use of sensing electrodes on a catheter (e.g., the same catheter that is used to perform the ablation). The sensing electrodes can be the same or different electrodes as those used to perform ablation. The sensing electrodes can monitor electrical signals within the cardiovascular system to pinpoint the location of aberrant conductive tissue sites that are responsible for the arrhythmia. Examples of an EP mapping system are described in U.S. Pat. No. 5,738,096, entitled “Cardiac Electromechanics,” issued Apr. 14, 1998 of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference. Examples of EP mapping catheters are described in U.S. Pat. No. 9,907,480, entitled “Catheter Spine Assembly with Closely-Spaced Bipole Microelectrodes,” issued Mar. 6, 2018; U.S. Pat. No. 10,130,422, entitled “Catheter with Soft Distal Tip for Mapping and Ablating Tubular Region,” issued Nov. 20, 2018; and U.S. Pub. No. 2018/0056038, entitled “Catheter with Bipole Electrode Spacer and Related Methods,” published Mar. 1, 2018, for each of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • EP mapping procedures may include the use of a reference electrode on a mapping catheter to sense electrical potentials in fluids near tissue. An example of such reference electrode is described in U.S. Pub. No. 2020/0038101, entitled “Unipolar reference electrode for electrophysiology mapping catheter,” published Feb. 6, 2020, of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • In addition to using EP mapping, some catheter ablation procedures may be performed using an image guided surgery (IGS) system. The IGS system may enable the physician to visually track the location of the catheter within the patient, in relation to images of anatomical structures within the patient, in real time. Some systems may provide a combination of EP mapping and IGS functionalities, including the CARTO system by Biosense Webster, Inc. of Irvine, Calif. Examples of catheters that are configured for use with an IGS system are disclosed in U.S. Pat. No. 9,480,416, entitled “Signal Transmission Using Catheter Braid Wires,” issued Nov. 1, 2016, of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference; and various other references that are cited herein and attached in the Appendix in the priority U.S. Provisional Patent Application 62/052,553.
  • SUMMARY
  • Examples presented herein generally include systems and methods which can contact electrodes to cardiac tissue while sensing electrical potential from fluids near the tissue. The electrodes in contact with the tissue can be carried by an end effector. The end effector sensors can be configured to ablate and/or sense electrical potentials from the cardiac tissue in which they are in contact. A reference electrode can be insulated by a shaft connected to the end effector so that the reference electrode can sense the electrical potentials from the fluids near the tissue while being prevented, by the shaft geometry, from contacting the cardiac tissue. The reference electrode can further serve as an extension of an irrigation tube positioned to irrigate the treatment area.
  • An example apparatus can include an elongated shaft, an end effector, and a reference electrode. A proximal portion of the elongated shaft can be manipulated to position a distal portion of the elongated shaft into a heart of a patient. The end effector can be disposed near the distal portion of the elongated shaft and can include spines each carrying at least one spine electrode. The spine electrodes can be positioned and otherwise configured to contact cardiovascular tissue. The spine electrodes can further be configured to receive electrical potentials from the tissue. The reference electrode can include a tubular, electrically conductive inner surface and an outer surface. The reference electrode can be disposed in the elongated shaft such that the electrode does not protrude beyond the elongated shaft. The inner surface can receive electrical potentials from fluids so that the electrical potentials received by the reference electrode act as a referential signal for the electrical potentials of tissue received by the electrodes carried by the spines. The outer surface of the reference electrode can be substantially electrically isolated from the electrical potentials of the fluids by an electrically insulating cover.
  • The apparatus can further include a connector joining the elongated shaft to the end effector. The connector can include the electrically insulating cover which electrically isolates the outer surface of the reference electrode.
  • The reference electrode can have a distal end approximately coplanar or coaxial to a distal end of the connector. The connector can be a distal extension of the shaft such that the reference electrode is approximately coplanar or coaxial with a distal end of the shaft by virtue of being approximately coplanar or coaxial with the distal end of the connector.
  • The connector can be capable of contacting the cardiovascular tissue while the spine electrodes are in contact with the cardiovascular tissue and while the reference electrode is electrically insulated, by the connector, from the cardiovascular tissue.
  • The end effector can have an unconstrained configuration aligned with a longitudinal axis of the apparatus and a particular geometry in the unconstrained configuration. The connector can include a tubular outer surface with a diameter measured orthogonal to the longitudinal axis. The end effector can have a height measured orthogonal to the longitudinal axis and a width measured orthogonal to the height and longitudinal axis when the end effector is in the unconstrained configuration. The height of the end effector can measure approximately equal to or less than the diameter of the tubular outer surface of the connector, and the width of the end effector can measure greater than the diameter of the tubular outer surface of the connector.
  • The apparatus can further include an irrigation tube in fluidic communication with the inner surface of the reference electrode. The reference electrode can function as a distal extension of the irrigation tube. The irrigation tube can be positioned within a lumen of the reference electrode and/or around the outer surface of the reference electrode. In addition, or as an alternative to the outer surface being electrically insulated by the connector joining the elongated shaft to the end effector, the outer surface of the reference electrode can be electrically insulated by a portion of the irrigation tube positioned over the outer surface of the reference electrode.
  • The spine electrodes can be positioned to preferably be distributed in a radially asymmetric pattern on the cardiovascular tissue in relation to the reference electrode's position when the plurality of spine electrodes are in contact with the cardiovascular tissue.
  • The spine electrodes can be positioned to form a rectangular grid when the plurality of spine electrodes are contact with the cardiovascular tissue.
  • The end effector can have a particular geometry including three loop members. Each of the loop members can include at least one of the spines (which each carry electrode positioned to contact tissue). The loop members can be joined at a common distal vertex. When the end effector is unconstrained, the distal vertex is aligned with a longitudinal axis defined by the elongated shaft. Each of the three loop members can include a respective pair of ends affixed to the distal portion of the elongated shaft. The end effector can deflect away from the unconstrained configuration at an angle relative to the longitudinal axis to position the spine electrodes against a planar surface.
  • The connector can secure each of the respective pair of ends of the loop members to the distal portion of the elongated shaft.
  • The end effector can deflect at an angle relative to the longitudinal axis to position the spine electrodes against a planar area of the cardiovascular tissue.
  • The spine electrodes can receive electrical potentials from the cardiovascular tissue when in contact with the cardiovascular tissue.
  • The spine electrodes can ablate when in contact with the cardiovascular tissue.
  • An example method can include one or more of the following steps presented in no particular order. An end effector can be assembled such that the end effector carries at least one spine electrode thereon that is configured to contact cardiovascular tissue and receive electrical potentials from the tissue. A reference electrode can be affixed in relation to the end effector such that a tubular inner surface of the reference electrode is configured to receive electrical potentials from fluids so that the electrical potential from the fluids act as a referential signal for the electrical potentials received by the spine electrodes. An outer surface of the reference electrode can be electrically insulated such that the outer surface is electrically isolated from the electrical potentials from fluids approximate the cardiovascular tissue while the inner surface is capable of receiving the electrical potentials of the fluids. The end effector and reference electrode can be affixed to a distal portion of an elongated shaft, the elongated shaft configured to be manipulated at a proximal portion of the elongated shaft to position the distal portion into a heart of a patient.
  • The method can further include joining the elongated shaft to the end effector with a connector and electrically insulating the outer surface of the reference electrode with the connector. The method can further include joining the end effector with the connector and an outer surface area of the reference electrode partially exposed electrode and positioned without the possibility of touching tissue.
  • The method can further include affixing the reference electrode and the connector such that a distal end of the reference electrode and a distal end of the connector are approximately coplanar and coaxial to each other. The connector can be a distal extension of the shaft such that the reference electrode is approximately coplanar or coaxial to the distal end of the shaft by virtue of being approximately coplanar or coaxial to the distal end of the connector.
  • The method can further include joining the elongated shaft to the end effector such that the connector is capable of contacting the cardiovascular tissue while the spine electrode is in contact with the cardiovascular tissue and while the reference electrode is electrically insulated, by the connector, from the cardiovascular tissue.
  • The method can further include assembling the end effector such that the end effector has an unconstrained configuration, and such that, when in the unconstrained configuration, the end effector has a height that is approximately equal to or less than a diameter of a tubular outer surface of the connector and the end effector has a width measuring greater than the diameter of the tubular outer surface of the connector, the diameter and height being measured orthogonal to a longitudinal axis defined by the elongated shaft, and the width being measured orthogonal to the longitudinal axis and direction of measurement of the height.
  • The method can further include positioning an irrigation tube within the elongated shaft such that the irrigation tube is in fluidic communication with the inner surface of the reference electrode.
  • The method can further include affixing the reference electrode to the irrigation tube such that the reference electrode is a distal extension of the irrigation tube.
  • The method can further include arranging the spine electrodes in a rectangular grid. Alternatively, the method can further include arranging the spine electrodes in a non-rectangular grid.
  • The method can further include shaping a first loop member, a second loop member and a third loop member to each form a respective loop; coupling a respective pair of ends for each of the first loop member, the second loop member, and the third loop member to the distal portion of the elongated shaft; joining the first loop member, the second loop member, and the third loop member at a common distal vertex distal to the distal portion of the elongated shaft; and configuring the end effector to be capable of deflecting at an angle relative to a longitudinal axis defined by the elongated shaft to position the spine electrodes against a planar surface.
  • The method can further include securing each of the respective pairs of ends to the distal portion of the elongated shaft with a connector and electrically insulating the outer surface of the reference electrode with the connector.
  • The method can further include configuring the end effector to deflect at an angle relative to the longitudinal axis to position the spine electrodes against a planar area of the cardiovascular tissue.
  • Another example method can include one or more of the following steps presented in no particular order. Steps of this example method are combinable with steps of the previous example method. A distal portion of the elongated shaft, and an end effector extending distally from a distal portion of the elongated shaft, can be moved through a catheter to a heart. The end effector can be moved from a distal end of the catheter via manipulation of a proximal portion of the elongated shaft. Spine electrodes, carried by the end effector, can be juxtaposed to cardiovascular tissue via manipulation of the proximal portion of the elongated shaft. While the spine electrodes are opposed to the cardiovascular tissue, electrical potentials from fluids approximate the cardiovascular tissue can be received via an inner surface of a reference electrode, an outer surface of the reference electrode being electrically insulated from the electrical potentials.
  • The method can further include contacting, to the cardiovascular tissue, while the spine electrodes are opposed (i.e., in physical contact) to the cardiovascular tissue, a connector joining the end effector to the distal portion of the elongated shaft and electrically insulating the outer surface of the reference electrode from the electrical potentials.
  • The method can further include irrigating the cardiovascular tissue through a lumen defined by the inner surface of the reference electrode.
  • The method can further include positioning the spine electrodes in a pattern on the cardiovascular tissue that is radially asymmetric in relation to the reference electrode's position.
  • The method can further include positioning the spine electrodes in a rectangular grid on the cardiovascular tissue.
  • The method can further include deflecting the end effector at an angle relative to a longitudinal axis defined by the elongated shaft to position the spine electrodes against the cardiovascular tissue. The cardiovascular tissue against which the spine electrodes are positioned being can be substantially planar.
  • The method can further include receiving, while the spine electrodes are opposed to the cardiovascular tissue, electrical potentials from the cardiovascular tissue via the spine electrodes.
  • The method can further include ablating the cardiovascular tissue via the spine electrodes, while the spine electrodes are opposed to the cardiovascular tissue.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is an illustration of a cardiovascular treatment apparatus having an end effector at a distal portion of an elongated shaft and a proximal handle at a proximal portion of the elongated shaft according to aspects of the present invention.
  • FIGS. 2A and 2B are illustrations of cross sectional views of an intermediate section and distal portion of a shaft of the apparatus in greater detail according to aspects of the present invention.
  • FIGS. 3A through 3C are various views of the end effector and distal portion of the shaft according to aspects of the present invention.
  • FIGS. 3D through 3F are illustrations of various views of the distal portion of the shaft according to aspects of the present invention.
  • FIGS. 4A through 4C are illustrations of the end effector being pressed to a planar surface according to aspects of the present invention.
  • FIGS. 5A and 5B are illustrations of cross sectional views of alternative reference electrode configurations according to aspects of the present invention.
  • FIG. 6 is an illustration of a treatment utilizing the cardiovascular treatment apparatus according to aspects of the present invention.
  • FIGS. 7A through 7F are illustrations of alternative end effectors having loop members and including an intralumenal reference electrode according to aspects of the present invention.
  • FIG. 8 is an illustration of an alternative end effector having a ray geometry and including an intralumenal reference electrode according to aspects of the present invention.
  • FIG. 9 is an illustration of another alternative end effector including an intralumenal reference electrode according to aspects of the present invention.
  • DETAILED DESCRIPTION
  • The following description of certain examples of the invention should not be used to limit the scope of the present invention. The drawings, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. Other examples, features, aspects, embodiments, and advantages of the invention will become apparent to those skilled in the pertinent art from the following description, which includes by way of illustration, one of the best modes contemplated for carrying out the invention. As will be realized, the invention is capable of other different or equivalent aspects, all without departing from the invention. Accordingly, the drawings and descriptions should be regarded as illustrative in nature and not restrictive.
  • Teachings, expressions, versions, examples, etc. described herein may be combined with other teachings, expressions, versions, examples, etc. that are described herein, including those examples provided in the references attached in the Appendix hereto. The following-described teachings, expressions, versions, examples, etc. should therefore not be viewed in isolation relative to each other. Various suitable ways in which the teachings herein may be combined are apparent to those skilled in the pertinent art in view of the teachings herein. Such modifications and variations are intended to be included within the scope of the claims.
  • As used herein, the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. More specifically, “about” or “approximately” may refer to the range of values±10% of the recited value, e.g. “about 90%” may refer to the range of values from 81% to 99%. In addition, as used herein, the terms “patient,” “host,” “user,” and “subject” refer to any human or animal subject and are not intended to limit the systems or methods to human use, although use of the subject invention in a human patient represents a preferred embodiment.
  • As used herein, the term “non-transitory computer-readable media” includes, but is not limited to, random access memory (RAM), read-only memory (ROM), electronically erasable programmable ROM (EEPROM), flash memory or other memory technology, compact disc ROM (CD-ROM), digital versatile disks (DVD) or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other tangible, physical medium which can be used to store computer readable information.
  • As used herein, the terms “tubular” and “tube” are to be construed broadly and are not limited to a structure that is a right cylinder or strictly circumferential in cross-section or of a uniform cross-section throughout its length. For example, the tubular structure or system is generally illustrated as a substantially right cylindrical structure. However, the tubular system may have a tapered or curved outer surface without departing from the scope of the present invention.
  • As used herein, the term “wire” can include elongated solid core and hollow core structures. When used to refer to an electrical conductor, the term wire “wire” can include insulated, non-insulated, individual, bundled, and integrated circuit conductors.
  • FIG. 1 illustrates an example apparatus 10 having an elongated shaft 9, a distal electrode assembly or end effector 100, and a deflection control handle 16. The apparatus 10 can have several design variations while including novel aspects illustrated herein. The apparatus 10 is presented for illustration purposes only and is not intended to be limiting. Details of the apparatus can be understood with reference to U.S. Patent Application Ser. No. 63/031,955 to which the present application claims the benefits of priority and which is incorporated herein by reference.
  • The elongated shaft 9 has a proximal portion 12 in the shape of an elongated catheter body, an intermediate deflection section 14, and distal portion 14A. The deflection control handle 16 is attached to the proximal end of the catheter body 12. The distal portion 14A of the shaft is coupled to the end effector 100 via a connector tubing 46. The connector tubing 46 is considered herein to be a distal extension of the elongated shaft such that the connector tubing 46 is considered a part of the elongated shaft 9. The elongated shaft 9 forms a tubular catheter body sized and otherwise configured to traverse vasculature. The proximal portion 12 of the elongated shaft 9 can be manipulated (e.g. via the handle 16) to position the distal portion 14A of the shaft 9 into a heart of a patient. The end effector 100 has a plurality of loop members 1, 2, 3 that overlap at a common distal vertex 50. The loop members 1, 2, 3 can be joined at the distal vertex 50 by a mechanical linkage.
  • The end effector 100 is illustrated in an unconstrained configuration. When the device is unconstrained and aligned, the proximal portion 12, intermediate section 14, distal portion 14A, and end effector 100 are generally aligned along a longitudinal axis A-A. The elongated shaft 9 can define the longitudinal axis A-A of the apparatus 10. The intermediate section 14 can be configured to bend to deflect the distal portion 14A and end effector 100 from the longitudinal axis A-A similar to as described in U.S. Pat. No. 9,820,664 (see FIGS. 6 and 7) incorporated by reference herein in its entirety and attached in the appendix hereto. Details of the apparatus can be understood with reference to U.S. Patent Application Ser. No. 63/031,955.
  • The end effector 100 can be collapsed (compressed toward the longitudinal axis A-A) to fit within a guiding sheath or catheter (not illustrated). The shaft 9 can be pushed distally to move the end effector 100 distally through the guiding sheath. The end effector 100 can be moved to exit a distal end of the guiding sheath via manipulation of the shaft 9 and/or control handle 16. An example of a suitable guiding sheath for this purpose is the Preface Braided Guiding Sheath, commercially available from Biosense Webster, Inc. (Irvine, Calif., USA).
  • The end effector 100 has first, second and third loop members 1, 2, and 3. Each loop member 1, 2, 3 has two spines 1A, 1B, 2A, 2B, 3A, 3B and a connector 1C, 2C, 3C that connects the two spines of the respective loop member 1, 2, 3. Spines 1A, 1B of the first loop member 1 are connected by a first connector 1C; spines 2A, 2B of the second loop member 2 are connected by a second connector 2C; and spines 3A, 3B of the third loop member 3 are connected by a third connector 3C. Each loop member 1, 2, 3 further has a respective pair of ends affixed to the distal portion 14A of the elongated shaft 9 (e.g. affixed to the connector 46 which is an extension of the distal portion 14A of the elongated shaft 9).
  • For each loop member 1, 2, 3 the spines 1A, 1B, 2A, 2B, 3A, 3B in the respective pair of spines can be substantially parallel to each other along a majority of their respective lengths when the end effector 100 is expanded in an unconstrained configuration as illustrated in FIG. 1. Preferably, all spines in the end effector are parallel to each other along the majority of their respective lengths when the end effector 100 is in the unconstrained configuration. Even when all spines are parallel, the spines are not necessarily all coplanar. Details of the apparatus can be understood with reference to U.S. Patent Application Ser. No. 63/031,955.
  • Each spine 1A, 1B, 2A, 2B, 3A or 3B can have a length ranging between about 5 and 50 mm, preferably between about 10 and 35 mm, and more preferably about 28 mm. The parallel portions of each spine 1A, 1B, 2A, 2B, 3A, 3B can be spaced apart from each other by a distance ranging between about 1 mm and 20 mm, preferably between about 2 and 10 mm, and more preferably about 4 mm. Each spine 1A, 1A, 1B, 2A, 2B, 3A, 3B preferably carries at least eight electrodes per spine member. The end effector preferably includes six spines as illustrated. With eight electrodes on six spines, the end effector 100 includes forty-eight electrodes. The spine electrodes 37 can be positioned and otherwise configured to contact cardiovascular tissue. The spine electrodes 37 can be configured to receive electrical potentials from tissue that they are in contact with and/or ablate the tissue.
  • FIG. 1 is illustrated as including a distal electrode 38D and a proximal electrode 38P positioned near the distal portion 14A of the shaft 9. The electrodes 38D and 38P can be configured to cooperate (e.g. by masking of a portion of one electrode and masking a different portion on the other electrode) to define a referential electrode (an electrode that is not in contact with tissues). As illustrated in greater detail in FIGS. 3A through 3F, the apparatus 10 can include a reference electrode 5 positioned within the connector tubing 46 so that is it is prevented from contacting tissue by the connector tubing 46. The reference electrode 5 can be used in addition to, or in place of one or both of the distal electrode 38D and the proximal electrode 38P illustrated in FIG. 1. Due to the likelihood of the electrodes 38D and 38P coming into contact with tissues, it is preferable that reference electrode 5 is utilized by itself.
  • In some unipolar EP mapping techniques, it can be desirable to obtain a reference potential from blood near the tissue at which a tissue potential is being picked up. In other words, it may be desirable to place a first electrode in contact with tissue to thereby pick up an electrical potential from the tissue; and place a second electrode in electrical communication with blood near the contacted tissue to thereby pick up a reference electrical potential from the blood. The reference electrode can be in direct contact with the blood and/or be in electrical communication with the blood via other fluids such as irrigation fluid. The second (reference) electrode can be configured such that it is prevented from contacting tissue while maintaining electrical communication with blood. By having the second (reference) electrode avoid contact with tissue, the second (reference) electrode may avoid pickup of local tissue potentials that might otherwise compromise the reliability of the sensed reference potential. This configuration can provide benefits similar to those obtained using bipolar EP mapping devices and techniques, such as reduced noise and reduced far field signals, due to the location of the reference electrode being in the same heart chamber as tissue-contacting electrodes; while still maintaining features of a unipolar signal.
  • Referring again to FIG. 1, it is expected that when the end effector 100 is pressed to tissue, one side of each of the reference electrodes 38D, 38P on the outside shaft 9 may contact tissue while the opposite side of each of the shaft reference electrodes 38D, 38P faces away from the tissue. The electrodes 38D, 38P can be masked with an electrical insulator on opposite sides such that when an unmasked side of one of the electrodes is against tissue, an unmasked side of the other electrode is facing away from the tissue; meaning, if one of the shaft reference electrodes 38D, 38P is in electrical contact with tissue, the other of the shaft electrodes 38D, 38P is insulated from the tissue by an electrically insulating mask.
  • Examples presented herein include a reference electrode 5 that has an electrically insulated outer surface such that electrically conductive portions of the reference electrode 5 are prevented from ever coming into contact with tissue. This eliminates the need for two electrodes (e.g. aforementioned shaft electrodes 38D, 38P) thereby reducing wires and bulk. The end effector 100 can be joined to the connector tubing 46 such that an outer surface area of the reference electrode 5 is partially exposed electrically and the exposed outer surface is positioned to prohibit the possibility that the exposed outer surface touches tissue during treatment.
  • One or more impedance sensing electrodes 38R can be configured to allow for location sensing via impedance location sensing technique, as described in U.S. Pat. Nos. 5,944,022; 5,983,126; and 6,445,864, for each of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • FIGS. 2A and 2B illustrate the intermediate section 14 and distal portion 14A of the shaft 9 of the apparatus in greater detail. FIG. 2A is a cross-sectional view, along the longitudinal axis A-A, of the elongated shaft 9 at the interface between the proximal portion 12 and intermediate section 14. FIG. 2B is a cross-sectional view of the intermediate section 14 orthogonal to the longitudinal axis A-A.
  • As illustrated in FIG. 2A, the catheter body 12 can be an elongated tubular construction having a single axial passage or central lumen 18. The central lumen 18 can be sized to allow an irrigation tube 15 to pass therethrough. The catheter body 12 is flexible, i.e., bendable, but substantially non-compressible along its length. The catheter body 12 can be of any suitable construction and made of any suitable material. In some embodiments, the catheter body 12 has an outer wall 20 made of polyurethane or PEBAX. The outer wall 20 may include an imbedded braided mesh of stainless steel or the like to increase torsional stiffness of the catheter body 12 so that, when the control handle 16 is rotated, the intermediate section 14 will rotate in a corresponding manner.
  • The outer diameter of the catheter body 12 is preferably no more than about 8 French, more preferably about 7 French. The thickness of the outer wall 20 is thin enough so that the central lumen 18 can accommodate at least one puller wire, one or more lead wires, and any other desired wires, cables or tubes (e.g. irrigation tube 15). If desired, the inner surface of the outer wall 20 is lined with a stiffening tube 22 to provide improved torsional stability. In some embodiments, the outer wall 20 has an outer diameter of from about 0.090 inch to about 0.094 inch (from about 2.3 mm to about 2.4 mm) and an inner diameter of from about 0.061 inch to about 0.065 inch (from about 1.5 mm to about 1.7 mm).
  • As illustrated particularly in FIG. 2B, the intermediate section 14 can include a shorter section of tubing 19 having multiple lumens, for example, four off- axis lumens 31, 32, 33, 34 and a central lumen 35. The first lumen 31 carries a plurality of lead wires 40S for ring electrodes 37 carried on the spines 1A, 1B, 2A, 2B, 3A, 3B. The second lumen 32 carries a first puller wire 24. The third lumen 33 carries a cable 36 for an electromagnetic position sensor 42 and lead wires 40D and 40P for distal and proximal ring electrodes 38D and 38P carried on the catheter proximally of the end effector 100 and/or the reference electrode 5 within the tubing 46.
  • Electromagnetic location sensing technique is described in U.S. Pat. Nos. 5,391,199; 5,443,489; 5,558,091; 6,172,499; 6,590,963; and 6,788,967, for each of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference. The magnetic location sensor 42 can be utilized with impedance sensing electrode 38R in a hybrid magnetic and impedance position sensing technique known as ACL described in U.S. Pat. Nos. 7,536,218; 7,756,567; 7,848,787; 7,869,865; and 8,456,182, for each of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • The fourth lumen 34 (for example, diametrically opposite of the second lumen 32 as illustrated) carries a second puller wire 26. The fifth, central lumen 35 carries the irrigation tube 15.
  • The tubing 19 is made of a suitable non-toxic material that is preferably more flexible than the catheter body 12. One suitable material for the tubing 19 is braided polyurethane, i.e., polyurethane with an embedded mesh of braided stainless steel or the like. The size of each lumen is sufficient to house the lead wires, puller wires, the cable and any other components.
  • The useful length of the catheter shaft 9, i.e., that portion of the apparatus 10 that can be inserted into the body excluding the end effector 100, can vary as desired. Preferably the useful length ranges from about 110 cm to about 120 cm. The length of the intermediate section 14 (measured from the connection to the catheter body 12 to the distal end of the shaft 9) is a relatively smaller portion of the useful length, and preferably ranges from about 3.5 cm to about 10 cm, more preferably from about 5 cm to about 6.5 cm.
  • Catheter body proximal portion 12 can be attached to the intermediate section 14 similar to as shown and described in FIGS. 2A and 2B of U.S. Pat. No. 9,820,664, of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference. If desired, a spacer (not shown) can be located within the catheter body 12 between the distal end of the stiffening tube (if provided) and the proximal end of the intermediate section 14. The spacer can provide a transition in flexibility at the junction of the catheter body 12 and intermediate section 14, which can allow this junction to bend smoothly without folding or kinking. A catheter having such a spacer is described in U.S. Pat. No. 5,964,757, of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • The distal portion 14A of the shaft 9 can be substantially contiguous with the intermediate section 14 such that the intermediate section comprises the distal portion 14A; the distal portion being distinguished from the intermediate section 14 by the positioning of one or more (optional) ring electrodes 38R. As referred to herein, the distal portion 14A of the shaft 9 can therefore correspond to a distal portion of the intermediate section 14. The connector tubing 46 can also be considered a distal extension of the shaft 9 so that it is understood that the connector tubing 46 is included in the distal portion 14A of the shaft.
  • FIGS. 3A through 3C illustrate the end effector and distal portion of the shaft 9 (connector tubing 46) in various orientations where the connector tubing is illustrated as translucent and all components within the connector tubing are made invisible with the exception of the reference electrode 5 and the irrigation tube 15 for the purposes of illustration. The connector tubing 46 can further house ends of support frames which extend through the loop members 1, 2, 3 to secure the loop members 1, 2, 3 to the shaft 9 similar to the apparatus described and illustrated in U.S. Patent Application Ser. No. 63/031,955. The connector tubing 46 can further house electrical conductors 36, 40D, 40P, 40S such as those illustrated in FIGS. 2A and 2B.
  • FIGS. 3D through 3F illustrate the connector tubing in various orientations with the end effector 100 made invisible for the purpose of illustration.
  • A Cartesian x, y, z axis is illustrated in each of the FIGS. 3A through 3F to illustrate relative orientations for each of the illustrations.
  • Referring collectively to FIGS. 3A through 3F, the reference electrode 5 can include a tubular inner surface 5B and a tubular outer surface 5C. The inner tubular surface 5B can be electrically conductive. The inner surface 5B can be positioned and otherwise configured so that fluids near cardiovascular tissue (e.g. blood and/or irrigation fluid) are in contact with the inner surface 5B when the spine electrodes 37 are in contact with cardiovascular tissue. The inner surface 5B can receive electrical potentials from these fluids so that the electrical potentials received by the reference electrode act as a referential signal for the electrical potentials of the electrodes 37 carried by the spines 1A, 1B, 2A, 2B, 3A, 3B.
  • The reference electrode 5 can be disposed in the elongated shaft 9 (being disposed in the connector 46 which is a distal extension of the shaft 9) such that the electrode does not protrude beyond the elongated shaft 9. The outer surface 5C of the reference electrode 5 can be substantially electrically isolated from the electrical potentials of the fluids. The connector 46 of the shaft 9 can serve as an insulating cover which electrically isolates the outer surface 5C. The reference electrode 5 can have a distal end 5A that is approximately coaxial or coplanar with a distal end 46A of the connector 46 (which corresponds to a distal end of the shaft 9). The term “coplanar” as used in relation to the reference electrode distal end 5A and the distal end 46A means that a plane may intersect both 5A and 46A so that both ends (5A and 46A) are on the same plane. In the example shown in FIG. 3D, a virtual plane (not shown) intersects surface 5C and 46A orthogonally so that both ends 5A and 46A are on the same plane. The term “coaxial” indicates that the longitudinal axis of connector 46 and the longitudinal axis of the reference electrode 5 are coincident with each other. The connector 46 can be capable of contacting the cardiovascular tissue while the spine electrodes are in contact with the cardiovascular tissue and while the reference electrode 5 is electrically insulated, by the connector, from the cardiovascular tissue as illustrated in greater detail in FIG. 4C.
  • The irrigation tube can be in fluidic communication with the inner surface 5B of the reference electrode 5. Fluids can flow through the irrigation tube and out of the shaft 9 through the reference electrode 5 so that the reference electrode 5 serves as a distal extension of the irrigation tube 15.
  • As illustrated in FIGS. 3A and 3B, the end effector 100 can have an unconstrained configuration aligned with a longitudinal axis A-A of the apparatus 10 and a flattened or paddle shaped geometry in the unconstrained configuration. The end effector 100 can have a height H and a width W measured as indicated in FIGS. 3A and 3B, the height H being significantly smaller than the width W. Further, compared to the dimensions of the connector 46, the height H of the end effector 100 can be about equal to, or smaller than, a diameter D1 of a tubular outer surface of the connector 46, where the diameter D1 is measured as indicated in FIG. 3A. The width W of the end effector 100 can be substantially greater than the diameter D1 of the connector 46. The end effector can have a length L measured as indicated in FIG. 3A that is greater still than the width W.
  • Having the paddle shape, the spine electrodes 37 are all positioned in a distal direction in relation to the reference electrode 5. When pressed to a surface, the spine electrodes 37 and references electrode 5 can roughly maintain their relative positions to each other compared to the unconstrained configuration. This results in the spine electrodes 37 being positioned to preferably be distributed in a radially asymmetric pattern on the cardiovascular tissue in relation to the reference electrode's position when the plurality of spine electrodes 37 are in contact with the cardiovascular tissue. In other words, the reference electrode 5 is positioned to one side of the collection of spine electrodes 37 when the electrodes 5, 37 are in operation during a treatment. This in contrast to other end effector geometries, such as illustrated in FIG. 8 where spines of the end effector extend radially from the reference electrode 5 so that it is possible to preferably distribute spine electrodes in a radially symmetric pattern on the cardiovascular tissue in relation to the reference electrode's position. Paddle shaped end effectors such as illustrated in FIGS. 7A through 7F also include spine electrodes positioned to be distributed in a radially asymmetric pattern on tissue in relation to the reference electrode's position.
  • The spine electrodes 37 can be positioned to form a rectangular grid when the spine electrodes 37 are contact with the cardiovascular tissue. Alternatively, the spine electrodes 37 can be positioned to form a non-rectangular grid; e.g. a circular, triangular, or other such shape.
  • As illustrated in greater detail in FIGS. 3D and 3E, the irrigation tube 15 can be positioned within a lumen of the reference 5 electrode. The apparatus 10 can further include an irrigation tube cover 45 to act as a fluid impermeable seal between the reference electrode 5 and the irrigation tube 15.
  • The distal end 5A of the electrode 5 is approximately co-planar with the distal end 46A of the connector 46 or even recessed (FIG. 3E) so that the electrode 5 does not protrude from the shaft 9 (e.g., FIG. 1). An insulating material 51 can be provided between the outer surface 5C of the electrode 5 and the inside surface 46B of connector 46. In one embodiment, material 51 can be a polymer such as for example, polyurethane. Configured as such, insulating material 51 insulates the outer surface 5C of the electrode 5 to prevent the outer surface 5C from coming into electrical contact with tissue during use. At the same time, however, inner surface 5C of reference electrode 5 is able to have electrical and physical contact with the biological fluid in the organ (e.g., blood) in order to receive or record the electrical signals propagated in the fluid. It is noted that irrigation line 15 can also work in reverse, by aspirating or sucking blood from the organ into the irrigation line 15. This allows for the reference electrode 5 to receive or sense electrical signals (via wiring 5D or electrical trace) in the blood significantly better because the blood is pulled into irrigation tube 15 allowing immersion of the conductive inner surface 5C with the blood pulled into irrigation tube 15.
  • As illustrated in greater detail in FIG. 3F, the connector 46 can include a collar 41 forming the outer surface 46A of the connector 46 and an insert 43 positioned in the collar 41. The insert 43 can include openings 44 shaped to receive ends of the loop members 1, 2, 3 and a central lumen 48 sized to house the reference electrode 45. A polymer can be flowed into the collar 41 and insert 43 to help secure the loop members 1, 2, 3 and reference electrode 5 in the connector 46.
  • FIGS. 4A through 4C are illustrations of the end effector 100 being pressed to a surface S. The end effector 100 can deflect at an angle θ relative to the longitudinal axis A-A to position the spine electrodes 37 to the surface S. The surface S is illustrated as planar; however, the surface can be curved. For instance, the surface S can have curvature consistent with intracardiac tissue surfaces.
  • FIG. 4A illustrates the end effector 100 having a portion of spine electrodes 37 pressed to the surface S and another portion of the spine electrodes 37 above the surface S, not in contact with the surface S.
  • FIG. 4B illustrates the connector 46 positioned above the surface S with all spine electrodes 37 in contact with the surface. The end effector 100 is deflected an angle θ relative to the longitudinal axis A-A that is nearly 90°. At such an angle, were the reference electrode 5 positioned such that it protruded from the shaft 9, depending on the length of protrusion and the distance between the distal end 46A of the connector 46 and the surface S, the reference electrode 5 may come into contact with the surface S. If the reference electrode 5 were to make electrical contact with the surface S, it can reduce the effectiveness of the reference electrode's ability to sense electrical potentials that can serve as reference electrical potentials. In other words, were the reference electrode 5 to come into electrical contact with tissue, it may not function as a reliable reference electrode. Positioning the reference electrode 5 so that it does not protrude from the connector 46 of the shaft 9 prevents the reference electrode 5 from contacting the surface S even when the end effector 100 is deflected at an angle of about 90° from the longitudinal axis A-A of the shaft 9.
  • FIG. 4C illustrates the connector 46 in contact with the surface S with all spine electrodes 37 in contact with the surface S. The end effector 100 is deflected at an acute angle θ relative to the longitudinal axis A-A. Having the connector 46 very near to the surface S and at a non-zero angle to the surface S, were the reference electrode 5 positioned such that it protruded from the shaft 9, depending on the length of protrusion and the angle θ, the reference electrode 5 may come into contact with the surface S. Positioning the reference electrode 5 so that it does not protrude from the connector 46 of the shaft 9 prevents the reference electrode 5 from contacting the surface S even when the connector 46 is in contact with the surface S and angled toward the surface S.
  • FIGS. 5A and 5B are illustrations of an alternative reference electrode configuration. The figures include a z axis to provide orientation relative to FIGS. 3A through 3F.
  • FIG. 5A is an illustration of a cross section of an alternative reference electrode configuration. Only the connector 46, reference electrode 5, and irrigation tube 5 are illustrated for the purposes of illustration. The apparatus 10 can include additional components not illustrated such as conductors and mechanical connection to the end effector 100 described elsewhere herein, including the Appendix. The irrigation tube 15 can be positioned around the outer surface 5C of the reference electrode 5. The transition from the irrigation tube 15 to the reference electrode 5 can be sealed to cause the reference electrode 5 to be an extension of the irrigation tube 15. In addition, or as an alternative to the outer surface 5C being electrically insulated by the connector 46, the outer surface 5C of the reference electrode 5 can be electrically insulated by a portion of the irrigation tube 15 positioned over the outer surface 5C of the reference electrode 5. In some configurations, such as illustrated, the irrigation tube 15 and reference electrode 5 can protrude from the elongated shaft so that the irrigation tube 15 prevents the outer surface 5C of the reference electrode 5 from coming into contact with tissue. For instance, the distal end 5A of the reference electrode 5 can be positioned in the irrigation tube 15 so that the reference electrode 5 does not protrude from the irrigation tube 15.
  • FIG. 5B is an illustration of a cross section of another alternative reference electrode configuration. In the alternative configuration, the reference electrode does not serve as an extension to the irrigation tube 15 but rather has an electrically conductive distal surface at its distal end 5A that is configured to receive electrical potentials from fluids that act as a reference signal for the electrical potentials from the spine electrodes 37. The electrically conductive surface at the distal end 5A of the reference electrode 5 is approximately coplanar or coaxial to the distal end 46A of the connector 46. Only the connector 46 and reference electrode 5 are illustrated for the purposes of illustration. The apparatus 10 can include additional components not illustrated such as conductors and mechanical connection to the end effector 100 described elsewhere herein, including in the Appendix.
  • FIG. 6 is an illustration of an exemplary medical procedure and associated components of a cardiac electrophysiology (EP) mapping catheter system that may utilize the apparatus 10 (also referred to as a catheter assembly). A physician PH is illustrated grasping the handle 16 of the apparatus, with the end effector 100 (not shown in FIG. 6) disposed in a patient PA to perform EP mapping in or near the heart H of the patient PA. The apparatus 10 is coupled with a guidance and drive system 110 via a cable 130. The apparatus 10 can optionally be coupled with a fluid source 142 via a fluid conduit 140. A set of field generators 120 are positioned underneath the patient PA and are coupled with guidance and drive system 110 via another cable 122. Field generators 120 are also optional.
  • The guidance and drive system 110 can include a console 112 and a display 118. The console 112 can include a first driver module 114 and a second driver module 116. The first driver module 114 can be coupled with the apparatus via a cable 130. In some variations, the first driver module 114 is operable to receive EP mapping signals obtained via spine electrodes 37 of end effector 100. The console 112 can include a processor (not shown) that processes such EP mapping signals and thereby provides EP mapping. In addition, or in the alternative, the first driver module 114 may be operable to provide RF power to the spine electrodes 37 of end effector 100 to thereby ablate tissue. In some versions, the first driver module 114 is also operable to receive position indicative signals from a position sensor in end effector 100. In such versions, the processor of console 112 is also operable to process the position indicative signals from the position sensor to thereby determine the position of the end effector 100 within the patient PA.
  • The guidance and drive system 110 can further include non-transitory computer readable medium with instructions thereon to case the drive system 110 to perform functionality described herein and/or as are known related to use of similar equipment. In some examples, the non-transitory computer readable memory can be in communication with the first driver module 114 (e.g. by virtue of being in communication with a processor of the first driver module 114 and/or the processor of the console 112). The non-transitory computer readable medium can include instructions thereon that when executed by the first driver module 114 cause the first driver module 114 to receive EP mapping signals from the spine electrodes 37 and a reference signal from the reference electrode 5.
  • The second driver module 116 is coupled with field generators 120 via a cable 122. The second driver module 116 is operable to activate field generators 120 to generate an alternating magnetic field around the heart H of the patient PA. For instance, the field generators 120 may include coils that generate alternating magnetic fields in a predetermined working volume that contains the heart H.
  • Some versions of the apparatus 10 include a position sense near or within the end effector 100 that is operable to generate signals that are indicative of the position and orientation of end effector 100 within the patient PA. Each position sensor may include a wire coil or a plurality of wire coils (e.g., three orthogonal coils) that are configured to generate electrical signals in response to the presence of an alternating electromagnetic field generated by field generators 120. Other components and techniques that may be used to generate real-time position data associated with end effector 100 may include wireless triangulation, acoustic tracking, optical tracking, inertial tracking, and the like. By way of example only, position sensing may be provided in accordance with at least some of the teachings of U.S. Pat. No. 9,480,416, of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference. Alternatively, apparatus 10 may lack a position sensor near the end effector 100.
  • The display 118 is coupled with the processor of console 112 and is operable to render images of patient anatomy. Such images may be based on a set of preoperatively or intraoperatively obtained images (e.g., a CT or MRI scan, 3-D map, etc.). The views of patient anatomy provided through the display 118 may also change dynamically based on signals from the position sensor near the end effector 100.
  • The processor of the console 112 may also drive the display 118 to superimpose the current location of end effector 100 on the images of the patient's anatomy, such as by superimposing an illuminated dot, a crosshair, a graphical representation of end effector 100, or some other form of visual indication.
  • The fluid source 142 can include a bag containing saline or some other suitable irrigation fluid. The conduit 140 can include a flexible tube that is further coupled with a pump 144, which is operable to selectively drive fluid from the fluid source 142 to the irrigation tube 15 of the apparatus 10. In some variations, such as including a reference electrode 5 as configured in FIG. 5B, the conduit 140, fluid source 142, and pump 144 are omitted entirely.
  • FIGS. 7A through 7F are illustrations of alternative end effectors 100 a-f having loop members and including an intralumenal reference electrode 5 described elsewhere herein. The end effectors include a reference electrode that does not protrude from the shaft 9 and therefore is not visible in the views of the figures. The end effectors can otherwise be configured similarly to the end effectors illustrated in U.S. Pat. No. 9,820,664 (see FIGS. 8A through 8F), U.S. Pub. No. 2020/0038101, and U.S. Pub. No. 2020/0038101 (see FIGS. 10 through 15), for each of which a copy is provided in the priority U.S. Provisional Patent Application 63/052,553 and incorporated herein by reference.
  • FIG. 8 is an illustration of an alternative end effector 100 g having a ray geometry and including an intralumenal reference electrode according to aspects of the present invention. The end effector includes a reference electrode 5 that does not extend beyond the shaft 9. The end effector can otherwise be configured similarly to the end effectors illustrated in U.S. Pat. No. 9,907,480 (see FIG. 5), U.S. Pub. No. 2018/0056038 (see FIG. 5), and U.S. Pub. No. 2020/0038101 (see FIGS. 2 through 7, 19, and 20). It is noted that the reference electrode as described and illustrated herein can be utilized with an end effector having a basket configuration whereby each of the spines expand outward and converges towards a distal end is within the scope of the invention. One example of such basket configuration is shown exemplarily in U.S. Pat. No. 10,575,743B2, which is incorporated by reference herein.
  • FIG. 9 is an illustration of another alternative end effector 100 h including an intralumenal reference electrode according to aspects of the present invention. The end effectors include a reference electrode that does not protrude from the shaft 9 and therefore is not visible in the views of the figures. The end effector can otherwise be configured similarly to the end effectors illustrated in U.S. Pat. No. 9,820,664 (see FIGS. 5A through 7) and U.S. Pub. No. 2020/0038101 (see FIG. 16).

Claims (20)

What is claimed is:
1. An apparatus comprising:
an elongated shaft comprising a proximal portion and a distal portion, the elongated shaft configured to be manipulated at the proximal portion to position the distal portion into a heart of a patient;
an end effector disposed proximate the distal portion of the elongated shaft and comprising spines each carrying at least one spine electrode configured to contact cardiovascular tissue and receive electrical potentials from the tissue; and
a reference electrode comprising an inner surface and an outer surface disposed about a longitudinal axis extending along the elongated shaft, the reference electrode being disposed in the elongated shaft such that the electrode does not protrude beyond the elongated shaft,
the inner surface of the reference electrode being configured to receive electrical potentials from fluids that act as a referential signal for the electrical potentials of the at least one spine electrode, and
the outer surface of the reference electrode being electrically isolated from the electrical potentials of the fluids.
2. The apparatus of claim 1, further comprising:
a connector joining the elongated shaft to the end effector, the connector comprising the electrically insulating cover.
3. The apparatus of claim 2, the reference electrode comprising a distal end approximately coplanar to a distal end of the connector.
4. The apparatus of claim 2, the connector being capable of contacting the cardiovascular tissue while the spine electrodes are in contact with the cardiovascular tissue and the outer surface of the reference electrode is electrically insulated, by the connector, from the cardiovascular tissue.
5. The apparatus of claim 2,
the end effector comprising an unconstrained configuration aligned with a longitudinal axis of the apparatus,
the connector comprising a tubular outer surface comprising a diameter measured orthogonal to the longitudinal axis,
the end effector comprising a height measured orthogonal to the longitudinal axis and a width measured orthogonal to the height and longitudinal axis when the end effector is in the unconstrained configuration,
the height measuring approximately equal to or less than the diameter of the tubular outer surface of the connector, and
the width measuring greater than the diameter of the tubular outer surface of the connector.
6. The apparatus of claim 1, further comprising:
an irrigation tube in fluidic communication with the inner surface of the reference electrode.
7. The apparatus of claim 6, the irrigation tube being configured in one mode to move irrigation fluid out of the irrigation tube and in another mode to move body fluids from an organ into the irrigation tube to allow for contact of the body fluids with the inner surface of the reference electrode.
8. The apparatus of claim 1, the spine electrodes positioned to form a grid when the spine electrodes are configured to contact with the cardiovascular tissue.
9. The apparatus of claim 1,
the elongated shaft defining a longitudinal axis of the apparatus,
the end effector comprising three loop members each comprising at least one of the spines and joined at a common distal vertex along the longitudinal axis,
each of the three loop members comprising a respective pair of ends affixed to the distal portion of the elongated shaft, and
the end effector configured to deflect at an angle relative to the longitudinal axis to position the spine electrodes against a planar surface.
10. The apparatus of claim 1, the spine electrodes being configured to receive electrical potentials from the cardiovascular tissue when in contact with the cardiovascular tissue.
11. The apparatus of claim 1, the spine electrodes being configured to ablate when in contact with the cardiovascular tissue.
12. The apparatus of claim 1, the reference electrode comprising a cylindrical member disposed about the longitudinal axis with the inner surface of the cylindrical member configured to contact with body fluids when placed into an organ.
13. A method comprising:
assembling an end effector such that the end effector comprises at least one spine electrode thereon configured to contact cardiovascular tissue and receive electrical potentials from the tissue;
affixing a reference electrode in relation to the end effector such that a tubular inner surface of the reference electrode does not contact cardiovascular tissue and is configured to receive electrical potentials from fluids that act as a referential signal for the electrical potentials received by the electrodes;
electrically insulating an outer surface of the reference electrode such that the outer surface is electrically isolated from the electrical potentials from fluids approximate the cardiovascular tissue while the inner surface is capable of receiving the electrical potentials of the fluids; and
affixing the end effector and reference electrode to a distal portion of an elongated shaft, the elongated shaft configured to be manipulated at a proximal portion of the elongated shaft to position the distal portion into a heart of a patient.
14. The method of claim 13, further comprising;
joining the elongated shaft to the end effector with a connector; and
electrically insulating a portion of the outer surface of the reference electrode with the connector so that an electrically exposed portion of the outer surface is positioned to preclude the exposed portion from coming into contact with tissue during treatment.
15. The method of claim 14, further comprising:
affixing the reference electrode and the connector such that a distal end of the reference electrode and a distal end of the connector are approximately coplanar and coaxial to each other.
16. The method of claim 14, further comprising:
joining the elongated shaft to the end effector such that the connector is capable of contacting the cardiovascular tissue while the spine electrode is in contact with the cardiovascular tissue and while the reference electrode is electrically insulated, by the connector, from the cardiovascular tissue.
17. The method of claim 14, further comprising:
positioning an irrigation tube within the elongated shaft such that the irrigation tube is in fluidic communication with the inner surface of the reference electrode.
18. A method comprising:
moving a distal portion of an elongated shaft and an end effector extending distally from the distal portion through a catheter to a heart;
moving the end effector from a distal end of the catheter via manipulation of a proximal portion of the elongated shaft;
opposing spine electrodes, carried by the end effector, to cardiovascular tissue via manipulation of the proximal portion of the elongated shaft; and
receiving, while the spine electrodes are opposed to the cardiovascular tissue, electrical potentials from fluids approximate the cardiovascular tissue via an inner surface of a reference electrode, an outer surface of the reference electrode being electrically insulated from the electrical potentials.
19. The method of claim 18, further comprising:
contacting, to the cardiovascular tissue, while the spine electrodes are opposed to the cardiovascular tissue, a connector joining the end effector to the distal portion of the elongated shaft and electrically insulating the outer surface of the reference electrode from the electrical potentials.
20. The method of claim 18, further comprising:
deflecting the end effector at an angle relative to a longitudinal axis defined by the elongated shaft to oppose the spine electrodes to the cardiovascular tissue; receiving, while the spine electrodes are opposed to the cardiovascular tissue, electrical potentials from the cardiovascular tissue via the spine electrodes; and
ablating the cardiovascular tissue via the spine electrodes, while the spine electrodes are opposed to the cardiovascular tissue.
US17/029,890 2020-05-29 2020-09-23 Intraluminal reference electrode for cardiovascular treatment apparatus Pending US20210369132A1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
US17/029,890 US20210369132A1 (en) 2020-05-29 2020-09-23 Intraluminal reference electrode for cardiovascular treatment apparatus
EP24202982.5A EP4477171B1 (en) 2020-09-30 Intraluminal reference electrode for cardiovascular treatment apparatus
EP24213973.1A EP4483828A3 (en) 2020-05-29 2020-09-30 Electrode apparatus for diagnosis of arrhythmias
IL277697A IL277697B2 (en) 2020-05-29 2020-09-30 Install electrodes to diagnose cardiac arrhythmias
EP20199175.9A EP3915477B1 (en) 2020-05-29 2020-09-30 Electrode apparatus for diagnosis of arrhythmias
JP2020164914A JP7512156B2 (en) 2020-05-29 2020-09-30 Intracluminal reference electrodes for cardiovascular devices
IL277699A IL277699B2 (en) 2020-05-29 2020-09-30 Intraluminal reference electrode for cardiovascular treatment apparatus
CN202011069986.XA CN113796869A (en) 2020-05-29 2020-09-30 Electrode device for diagnosing cardiac arrhythmias
CN202011055244.1A CN113796868A (en) 2020-05-29 2020-09-30 Intraluminal reference electrode for cardiovascular therapy device
EP20199230.2A EP3915501B1 (en) 2020-05-29 2020-09-30 Intraluminal reference electrode for cardiovascular treatment apparatus
JP2020164921A JP2021186647A (en) 2020-05-29 2020-09-30 Electrode apparatus for diagnosis of arrhythmias
EP23163381.9A EP4218579B1 (en) 2020-05-29 2020-09-30 Intraluminal reference electrode for cardiovascular treatment apparatus
EP22194803.7A EP4159124B1 (en) 2020-05-29 2020-09-30 Intraluminal reference electrode for cardiovascular treatment apparatus

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063031955P 2020-05-29 2020-05-29
US202063052553P 2020-07-16 2020-07-16
US17/029,890 US20210369132A1 (en) 2020-05-29 2020-09-23 Intraluminal reference electrode for cardiovascular treatment apparatus

Publications (1)

Publication Number Publication Date
US20210369132A1 true US20210369132A1 (en) 2021-12-02

Family

ID=78707119

Family Applications (2)

Application Number Title Priority Date Filing Date
US17/029,752 Active 2041-10-06 US12232874B2 (en) 2020-05-29 2020-09-23 Electrode apparatus for diagnosis of arrhythmias
US17/029,890 Pending US20210369132A1 (en) 2020-05-29 2020-09-23 Intraluminal reference electrode for cardiovascular treatment apparatus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US17/029,752 Active 2041-10-06 US12232874B2 (en) 2020-05-29 2020-09-23 Electrode apparatus for diagnosis of arrhythmias

Country Status (1)

Country Link
US (2) US12232874B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4115833A1 (en) 2021-07-09 2023-01-11 Biosense Webster (Israel) Ltd. Ablation and mapping with a singular multi-electrode catheter
US20240156524A1 (en) * 2022-11-11 2024-05-16 Biosense Webster (Israel) Ltd. Electrode catheter with corrugated support structure
EP4393426A2 (en) 2022-12-29 2024-07-03 Biosense Webster (Israel) Ltd. Multi-electrode catheter with interlaced substrate
EP4397264A1 (en) * 2022-12-28 2024-07-10 Biosense Webster (Israel) Ltd. Electrode arrangement for planar catheter end effector
US12263014B2 (en) 2020-08-18 2025-04-01 St. Jude Medical, Cardiology Division, Inc. High-density electrode catheters with magnetic position tracking
EP4566558A1 (en) * 2023-12-06 2025-06-11 Biosense Webster (Israel) Ltd. Reference electrode dedicated to catheter tissue proximity estimation
US12350050B2 (en) * 2014-04-14 2025-07-08 Recor Medical, Inc. Intraluminal microneurography probes and related systems and methods

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11850051B2 (en) 2019-04-30 2023-12-26 Biosense Webster (Israel) Ltd. Mapping grid with high density electrode array
US12232874B2 (en) 2020-05-29 2025-02-25 Biosense Webster (Israel) Ltd. Electrode apparatus for diagnosis of arrhythmias
WO2023007324A1 (en) 2021-07-30 2023-02-02 Biosense Webster (Israel) Ltd. Planar end effector with irrigation
US12478424B2 (en) 2021-09-10 2025-11-25 Biosense Webster (Israel) Ltd. Staggered pairs of biased ablation electrodes on basket catheter
US12484961B2 (en) 2022-01-20 2025-12-02 Biosense Webster (Israel) Ltd. Mechanical retainer systems for electrodes of a basket catheter, and methods of the same
US20230225788A1 (en) * 2022-01-20 2023-07-20 Biosense Webster (Israel) Ltd. Systems and methods for c-shaped spines forming a spherical basket for improved tissue contact and current delivery
US12440263B2 (en) 2022-01-20 2025-10-14 Biosense Webster (Israel) Ltd. Systems and methods for tripodic spines forming a spherical basket for improved tissue contact and current delivery
US20230337956A1 (en) * 2022-04-21 2023-10-26 Biosense Webster (Israel) Ltd. Collapsible electrode apparatus for diagnosis of arrhythmias
US12471989B2 (en) 2022-04-28 2025-11-18 Biosense Webster (Israel) Ltd. Strengthened expandable baskets for medical probes and medical probes containing strengthen expandable baskets
US20230380746A1 (en) * 2022-05-31 2023-11-30 Biosense Webster (Israel) Ltd. Catheter end effector providing mapping grid with high density electrode array and strain reduction
US20240197389A1 (en) 2022-12-16 2024-06-20 Biosense Webster (Israel) Ltd. Catheter with pull ring coupler
US20240215894A1 (en) 2022-12-30 2024-07-04 Biosense Webster (Israel) Ltd. Catheter with flexible polymer as outer support structure
US20240215920A1 (en) * 2022-12-30 2024-07-04 Biosense Webster (Israel) Ltd. Arrhythmia diagnosis electrode apparatus having reduced directional stiffness
IL312953A (en) 2023-06-02 2025-01-01 Biosense Webster Israel Ltd Double-Sided Encapsulated Planar Catheter
US20240398468A1 (en) * 2023-06-02 2024-12-05 Biosense Webster (Israel) Ltd. Basket catheter distal end feature
US20240407696A1 (en) 2023-06-09 2024-12-12 Biosense Webster (Israel) Ltd. Medical probe with concentric reference and sense electrodes
US20250032103A1 (en) 2023-07-24 2025-01-30 Biosense Webster (Israel) Ltd. Catheter end effector with nonplanar substrate
US20250032177A1 (en) 2023-07-28 2025-01-30 Biosense Webster (Israel) Ltd. Double-sided encapsulated planar catheter with encapsulating polymer
US20250213163A1 (en) 2023-12-28 2025-07-03 Biosense Webster (Israel) Ltd. Encapsulated catheters, systems, and methods associated therewith

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010001314A1 (en) * 1997-06-13 2001-05-17 Arthrocare Corporation Electrosurgical systems and methods for recanalization of occluded body lumens
US20030236455A1 (en) * 2000-10-05 2003-12-25 Scimed Life Systems, Inc. Probe assembly for mapping and ablating pulmonary vein tissue and method of using same
US20060253117A1 (en) * 1992-01-07 2006-11-09 Arthrocare Corporation Systems and methods for electrosurgical treatment of obstructive sleep disorders
US20130226167A1 (en) * 2004-11-05 2013-08-29 Asthmatx, Inc. Energy delivery devices and methods
US20140018788A1 (en) * 2012-07-04 2014-01-16 Zoar Jacob ENGELMAN Devices and Systems for Carotid Body Ablation
US20160073913A1 (en) * 2013-04-22 2016-03-17 Imperial Innovations Limited Image display interfaces
US20160143588A1 (en) * 2014-11-20 2016-05-26 Biosense Webster (Israel) Ltd. Catheter with high density electrode spine array
US20160346038A1 (en) * 2014-02-06 2016-12-01 St. Jude Medical, Cardiology Division, Inc. Elongate medical device including chamfered ring electrode and variable shaft
US20170007158A1 (en) * 2015-07-08 2017-01-12 Rainbow Medical Ltd. Hemodynamic-signal-based electrode-tissue contact detection
US20170296125A1 (en) * 2014-10-28 2017-10-19 Biosense Webster (Israel) Ltd. Basket catheter with microelectrode array distal tip
US20180185651A1 (en) * 2017-01-05 2018-07-05 Medtronic Bakken Research Center B.V. Impedance-based allocation of electrical stimulation to electrode clusters
US20200196893A1 (en) * 2018-02-05 2020-06-25 Mayo Foundation For Medical Education And Research Systems and methods for mapping and modulating repolarization

Family Cites Families (392)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6014590A (en) 1974-03-04 2000-01-11 Ep Technologies, Inc. Systems and methods employing structures having asymmetric mechanical properties to support diagnostic or therapeutic elements in contact with tissue in interior body regions
US5904680A (en) 1992-09-25 1999-05-18 Ep Technologies, Inc. Multiple electrode support structures having optimal bio-mechanical characteristics
US4699147A (en) 1985-09-25 1987-10-13 Cordis Corporation Intraventricular multielectrode cardial mapping probe and method for using same
US4940064A (en) 1986-11-14 1990-07-10 Desai Jawahar M Catheter for mapping and ablation and method therefor
US5215103A (en) 1986-11-14 1993-06-01 Desai Jawahar M Catheter for mapping and ablation and method therefor
US5365926A (en) 1986-11-14 1994-11-22 Desai Jawahar M Catheter for mapping and ablation and method therefor
US5415166A (en) 1991-02-15 1995-05-16 Cardiac Pathways Corporation Endocardial mapping apparatus and cylindrical semiconductor device mounting structure for use therewith and method
US5456254A (en) 1991-02-15 1995-10-10 Cardiac Pathways Corp Flexible strip assembly having insulating layer with conductive pads exposed through insulating layer and device utilizing the same
US5345936A (en) 1991-02-15 1994-09-13 Cardiac Pathways Corporation Apparatus with basket assembly for endocardial mapping
US5465717A (en) 1991-02-15 1995-11-14 Cardiac Pathways Corporation Apparatus and Method for ventricular mapping and ablation
US5383917A (en) 1991-07-05 1995-01-24 Jawahar M. Desai Device and method for multi-phase radio-frequency ablation
US5255679A (en) 1992-06-02 1993-10-26 Cardiac Pathways Corporation Endocardial catheter for mapping and/or ablation with an expandable basket structure having means for providing selective reinforcement and pressure sensing mechanism for use therewith, and method
US5324284A (en) 1992-06-05 1994-06-28 Cardiac Pathways, Inc. Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method
US5411025A (en) 1992-06-30 1995-05-02 Cordis Webster, Inc. Cardiovascular catheter with laterally stable basket-shaped electrode array
USRE41334E1 (en) 1992-09-23 2010-05-11 St. Jude Medical, Atrial Fibrillation Division, Inc. Endocardial mapping system
US5309910A (en) 1992-09-25 1994-05-10 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5293869A (en) 1992-09-25 1994-03-15 Ep Technologies, Inc. Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole
US5549108A (en) 1992-09-25 1996-08-27 Ep Technologies, Inc. Cardiac mapping and ablation systems
JPH08504333A (en) 1992-09-25 1996-05-14 イーピー・テクノロジーズ・インコーポレーテッド Electrode-supported splines for the cardiac system
WO1994021170A1 (en) 1993-03-16 1994-09-29 Ep Technologies, Inc. Flexible circuit assemblies employing ribbon cable
US5476495A (en) 1993-03-16 1995-12-19 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5893847A (en) 1993-03-16 1999-04-13 Ep Technologies, Inc. Multiple electrode support structures with slotted hub and hoop spline elements
US5725525A (en) 1993-03-16 1998-03-10 Ep Technologies, Inc. Multiple electrode support structures with integral hub and spline elements
WO1994021169A1 (en) 1993-03-16 1994-09-29 Ep Technologies, Inc. Flexible interlaced multiple electrode assemblies
CA2136988A1 (en) 1993-04-07 1994-10-13 Mir A. Imran Apparatus and method for ventricular mapping and ablation
US5391199A (en) 1993-07-20 1995-02-21 Biosense, Inc. Apparatus and method for treating cardiac arrhythmias
IL116699A (en) 1996-01-08 2001-09-13 Biosense Ltd Method of constructing cardiac map
US5738096A (en) 1993-07-20 1998-04-14 Biosense, Inc. Cardiac electromechanics
US5396887A (en) 1993-09-23 1995-03-14 Cardiac Pathways Corporation Apparatus and method for detecting contact pressure
US5558091A (en) 1993-10-06 1996-09-24 Biosense, Inc. Magnetic determination of position and orientation
US5526810A (en) 1993-10-07 1996-06-18 Wang; Dai-Yuen Intraventricular mapping catheter
US5400783A (en) 1993-10-12 1995-03-28 Cardiac Pathways Corporation Endocardial mapping apparatus with rotatable arm and method
US5881727A (en) 1993-10-14 1999-03-16 Ep Technologies, Inc. Integrated cardiac mapping and ablation probe
WO1995010320A1 (en) 1993-10-15 1995-04-20 Ep Technologies, Inc. Device for lengthening cardiac conduction pathways
US6071280A (en) 1993-11-08 2000-06-06 Rita Medical Systems, Inc. Multiple electrode ablation apparatus
WO1995020348A1 (en) 1994-01-28 1995-08-03 Ep Technologies, Inc. Matching electrical characteristics and propagation velocities to locate ablation sites
US5577509A (en) 1994-01-28 1996-11-26 Ep Technologies, Inc. Systems and methods for examining the electrical characteristics and timing of electrical events in cardiac tissue
US5911739A (en) 1994-03-04 1999-06-15 Ep Technologies, Inc. Structures for supporting diagnostic or therapeutic elements in internal body regions
US6216043B1 (en) 1994-03-04 2001-04-10 Ep Technologies, Inc. Asymmetric multiple electrode support structures
US5968040A (en) 1994-03-04 1999-10-19 Ep Technologies, Inc. Systems and methods using asymmetric multiple electrode arrays
US5598848A (en) 1994-03-31 1997-02-04 Ep Technologies, Inc. Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium
US5630918A (en) * 1994-06-13 1997-05-20 Tosoh Corporation ITO sputtering target
US6245068B1 (en) 1994-08-08 2001-06-12 Scimed Life Systems, Inc. Resilient radiopaque electrophysiology electrodes and probes including the same
US5885278A (en) 1994-10-07 1999-03-23 E.P. Technologies, Inc. Structures for deploying movable electrode elements
US5722401A (en) 1994-10-19 1998-03-03 Cardiac Pathways Corporation Endocardial mapping and/or ablation catheter probe
US6690963B2 (en) 1995-01-24 2004-02-10 Biosense, Inc. System for determining the location and orientation of an invasive medical instrument
IT1278369B1 (en) 1995-02-14 1997-11-20 Sorin Biomedica Cardio Spa CATHETER, PARTICULARLY FOR THE TREATMENT OF HEART ARRHYTHMIA.
IT1278372B1 (en) 1995-02-15 1997-11-20 Sorin Biomedica Cardio Spa CATHETER, PARTICULARLY FOR THE TREATMENT OF HEART ARRHYTHMIA.
US5595183A (en) 1995-02-17 1997-01-21 Ep Technologies, Inc. Systems and methods for examining heart tissue employing multiple electrode structures and roving electrodes
DE69622256T2 (en) 1995-02-17 2003-02-06 Boston Scientific Ltd., Saint Michael ARRANGEMENT FOR SEQUENTIAL MEASUREMENT OF BIOLOGICAL EVENTS
US5609157A (en) 1995-02-17 1997-03-11 Ep Technologies, Inc. Systems and methods for analyzing biopotential morphologies in body tissue using iterative techniques
WO1996034560A1 (en) 1995-05-02 1996-11-07 Heart Rhythm Technologies, Inc. Catheter with expandable probe
US5681280A (en) 1995-05-02 1997-10-28 Heart Rhythm Technologies, Inc. Catheter control system
US5702438A (en) 1995-06-08 1997-12-30 Avitall; Boaz Expandable recording and ablation catheter system
US5697377A (en) 1995-11-22 1997-12-16 Medtronic, Inc. Catheter mapping system and method
JP4072587B2 (en) 1996-02-15 2008-04-09 バイオセンス・ウェブスター・インコーポレイテッド Independently positionable transducer for position determination system
WO1997029709A1 (en) 1996-02-15 1997-08-21 Biosense, Inc. Medical procedures and apparatus using intrabody probes
US5722403A (en) 1996-10-28 1998-03-03 Ep Technologies, Inc. Systems and methods using a porous electrode for ablating and visualizing interior tissue regions
US5944022A (en) 1997-04-28 1999-08-31 American Cardiac Ablation Co. Inc. Catheter positioning system
US6014579A (en) 1997-07-21 2000-01-11 Cardiac Pathways Corp. Endocardial mapping catheter with movable electrode
US5964757A (en) 1997-09-05 1999-10-12 Cordis Webster, Inc. Steerable direct myocardial revascularization catheter
US6123699A (en) 1997-09-05 2000-09-26 Cordis Webster, Inc. Omni-directional steerable catheter
US6064721A (en) 1997-10-22 2000-05-16 Telecommunications Techniques Corporation Modular test instrument
US6171277B1 (en) 1997-12-01 2001-01-09 Cordis Webster, Inc. Bi-directional control handle for steerable catheter
US6183463B1 (en) 1997-12-01 2001-02-06 Cordis Webster, Inc. Bidirectional steerable cathether with bidirectional control handle
US6239724B1 (en) 1997-12-30 2001-05-29 Remon Medical Technologies, Ltd. System and method for telemetrically providing intrabody spatial position
US6522932B1 (en) 1998-02-10 2003-02-18 Advanced Bionics Corporation Implantable, expandable, multicontact electrodes and tools for use therewith
US6415187B1 (en) 1998-02-10 2002-07-02 Advanced Bionics Corporation Implantable, expandable, multicontact electrodes and insertion needle for use therewith
US6142993A (en) 1998-02-27 2000-11-07 Ep Technologies, Inc. Collapsible spline structure using a balloon as an expanding actuator
US6428537B1 (en) 1998-05-22 2002-08-06 Scimed Life Systems, Inc. Electrophysiological treatment methods and apparatus employing high voltage pulse to render tissue temporarily unresponsive
US6119030A (en) 1998-06-22 2000-09-12 Ep Technologies, Inc. Silicone tip for multiple electrode basket assemblies
US6198974B1 (en) 1998-08-14 2001-03-06 Cordis Webster, Inc. Bi-directional steerable catheter
US6210407B1 (en) 1998-12-03 2001-04-03 Cordis Webster, Inc. Bi-directional electrode catheter
US6183435B1 (en) 1999-03-22 2001-02-06 Cordis Webster, Inc. Multi-directional steerable catheters and control handles
US6267746B1 (en) 1999-03-22 2001-07-31 Biosense Webster, Inc. Multi-directional steerable catheters and control handles
ATE349949T1 (en) 1999-04-05 2007-01-15 Univ California ENDOMYOCARDIAL SINGLE-PHASE ACTION POTENTIALS FOR EARLY DETECTION OF MYOCARDIAL PATHOLOGY
US6172499B1 (en) 1999-10-29 2001-01-09 Ascension Technology Corporation Eddy current error-reduced AC magnetic position measurement system
US6892091B1 (en) 2000-02-18 2005-05-10 Biosense, Inc. Catheter, method and apparatus for generating an electrical map of a chamber of the heart
US6445864B2 (en) 2000-03-24 2002-09-03 Corning Incorporated Dispersion compensating optical fiber
DE60138880D1 (en) 2000-05-03 2009-07-16 Bard Inc C R DEVICE FOR MULTI-DIMENSIONAL PRESENTATION AND ABLATION IN ELECTROPHYSIOLOGICAL PROCEDURES
US6484118B1 (en) 2000-07-20 2002-11-19 Biosense, Inc. Electromagnetic position single axis system
US6837848B2 (en) 2003-01-15 2005-01-04 Medtronic, Inc. Methods and apparatus for accessing and stabilizing an area of the heart
US6584345B2 (en) 2001-03-13 2003-06-24 Biosense, Inc. Apparatus and method for measuring a plurality of electrical signals from the body of a patient
DE60230499D1 (en) 2001-04-27 2009-02-05 Bard Inc C R CATHETER FOR THE THREE-DIMENSIONAL ILLUSTRATION OF ELECTRIC ACTIVITY IN BLOOD VESSELS
US6741878B2 (en) 2001-12-14 2004-05-25 Biosense Webster, Inc. Basket catheter with improved expansion mechanism
US6748255B2 (en) 2001-12-14 2004-06-08 Biosense Webster, Inc. Basket catheter with multiple location sensors
US6961602B2 (en) 2001-12-31 2005-11-01 Biosense Webster, Inc. Catheter having multiple spines each having electrical mapping and location sensing capabilities
US6980858B2 (en) 2001-12-31 2005-12-27 Biosense Webster, Inc. Method and system for atrial defibrillation
DE60315427T2 (en) 2002-03-15 2008-04-30 C.R. Bard, Inc. APPARATUS FOR CONTROLLING ABLATION ENERGY AND ELECTROGRAMMING BY MEANS OF A VARIETY OF COMMON ELECTRODES IN AN ELECTROPHYSIOLOGY CATHETER
US6866662B2 (en) 2002-07-23 2005-03-15 Biosense Webster, Inc. Ablation catheter having stabilizing array
US6780183B2 (en) 2002-09-16 2004-08-24 Biosense Webster, Inc. Ablation catheter having shape-changing balloon
US7027851B2 (en) 2002-10-30 2006-04-11 Biosense Webster, Inc. Multi-tip steerable catheter
WO2004087249A2 (en) 2003-03-28 2004-10-14 C.R. Bard, Inc. Braided mesh catheter
US7559934B2 (en) * 2003-04-07 2009-07-14 Scimed Life Systems, Inc. Beaded basket retrieval device
US9101383B1 (en) * 2003-04-25 2015-08-11 Annex Medical, Inc. Medical retrieval device
US20040254572A1 (en) 2003-04-25 2004-12-16 Mcintyre Jon T. Self anchoring radio frequency ablation array
US7003342B2 (en) 2003-06-02 2006-02-21 Biosense Webster, Inc. Catheter and method for mapping a pulmonary vein
US7399299B2 (en) 2003-07-11 2008-07-15 S.D.M.H. Pty. Ltd. Thermal ablation of biological tissue
US7204640B2 (en) 2003-08-29 2007-04-17 Accuray, Inc. Apparatus and method for registering 2D radiographic images with images reconstructed from 3D scan data
ES2564694T3 (en) 2003-09-12 2016-03-28 Vessix Vascular, Inc. Selectable eccentric remodeling and / or ablation system of atherosclerotic material
US7155270B2 (en) 2003-10-24 2006-12-26 Biosense Webster, Inc. Catheter with multi-spine mapping assembly
US7366557B2 (en) 2003-11-07 2008-04-29 Biosense Webster, Inc. Flower catheter
US7326206B2 (en) 2004-01-16 2008-02-05 St. Jude Medical, Atrial Fibrillation Division, Inc. Conforming-electrode catheter and method for ablation
US8007495B2 (en) 2004-03-31 2011-08-30 Biosense Webster, Inc. Catheter for circumferential ablation at or near a pulmonary vein
US7591799B2 (en) 2004-06-14 2009-09-22 Biosense Webster, Inc. Steering mechanism for bi-directional catheter
US20060089637A1 (en) 2004-10-14 2006-04-27 Werneth Randell L Ablation catheter
US7848757B2 (en) 2004-10-29 2010-12-07 Samsung Electronics Co., Ltd. Apparatus and method for extending mobility in a mobile ad hoc network
US7429261B2 (en) 2004-11-24 2008-09-30 Ablation Frontiers, Inc. Atrial ablation catheter and method of use
US7869865B2 (en) 2005-01-07 2011-01-11 Biosense Webster, Inc. Current-based position sensing
US7848787B2 (en) 2005-07-08 2010-12-07 Biosense Webster, Inc. Relative impedance measurement
US7536218B2 (en) 2005-07-15 2009-05-19 Biosense Webster, Inc. Hybrid magnetic-based and impedance-based position sensing
US7756576B2 (en) 2005-08-26 2010-07-13 Biosense Webster, Inc. Position sensing and detection of skin impedance
JP2009535161A (en) * 2006-04-29 2009-10-01 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム Device for use in transmural and intraluminal surgery
US8048063B2 (en) 2006-06-09 2011-11-01 Endosense Sa Catheter having tri-axial force sensor
US8567265B2 (en) 2006-06-09 2013-10-29 Endosense, SA Triaxial fiber optic force sensing catheter
US7729752B2 (en) 2006-06-13 2010-06-01 Rhythmia Medical, Inc. Non-contact cardiac mapping, including resolution map
US7515954B2 (en) 2006-06-13 2009-04-07 Rhythmia Medical, Inc. Non-contact cardiac mapping, including moving catheter and multi-beat integration
US8744599B2 (en) 2007-03-09 2014-06-03 St. Jude Medical, Atrial Fibrillation Division, Inc. High density mapping catheter
US8979837B2 (en) 2007-04-04 2015-03-17 St. Jude Medical, Atrial Fibrillation Division, Inc. Flexible tip catheter with extended fluid lumen
US8187267B2 (en) 2007-05-23 2012-05-29 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation catheter with flexible tip and methods of making the same
US8764742B2 (en) 2007-04-04 2014-07-01 St. Jude Medical, Atrial Fibrillation Division, Inc. Irrigated catheter
US8517999B2 (en) 2007-04-04 2013-08-27 St. Jude Medical, Atrial Fibrillation Division, Inc. Irrigated catheter with improved fluid flow
EP2139416B1 (en) 2007-05-09 2015-08-19 Irvine Biomedical, Inc. Basket catheter having multiple electrodes
US10220187B2 (en) 2010-06-16 2019-03-05 St. Jude Medical, Llc Ablation catheter having flexible tip with multiple flexible electrode segments
US11395694B2 (en) 2009-05-07 2022-07-26 St. Jude Medical, Llc Irrigated ablation catheter with multiple segmented ablation electrodes
US20120010490A1 (en) 2010-06-16 2012-01-12 Kauphusman James V Medical devices having flexible electrodes mounted thereon
US8734440B2 (en) 2007-07-03 2014-05-27 St. Jude Medical, Atrial Fibrillation Division, Inc. Magnetically guided catheter
WO2009023385A1 (en) 2007-07-03 2009-02-19 Irvine Biomedical, Inc. Magnetically guided catheter with flexible tip
US10492729B2 (en) 2007-05-23 2019-12-03 St. Jude Medical, Cardiology Division, Inc. Flexible high-density mapping catheter tips and flexible ablation catheter tips with onboard high-density mapping electrodes
US8974454B2 (en) 2009-12-31 2015-03-10 St. Jude Medical, Atrial Fibrillation Division, Inc. Kit for non-invasive electrophysiology procedures and method of its use
US8906011B2 (en) 2007-11-16 2014-12-09 Kardium Inc. Medical device for use in bodily lumens, for example an atrium
CN101888813B (en) 2007-12-06 2012-12-12 皇家飞利浦电子股份有限公司 Apparatus, a method and a computer program for applying energy to an object
US8103327B2 (en) 2007-12-28 2012-01-24 Rhythmia Medical, Inc. Cardiac mapping catheter
US8235988B2 (en) 2008-01-24 2012-08-07 Coherex Medical, Inc. Systems and methods for reduction of atrial fibrillation
US8157848B2 (en) 2008-02-01 2012-04-17 Siemens Medical Solutions Usa, Inc. System for characterizing patient tissue impedance for monitoring and treatment
US8456182B2 (en) 2008-09-30 2013-06-04 Biosense Webster, Inc. Current localization tracker
EP2349440B1 (en) 2008-10-07 2019-08-21 Mc10, Inc. Catheter balloon having stretchable integrated circuitry and sensor array
US9339331B2 (en) 2008-12-29 2016-05-17 St. Jude Medical, Atrial Fibrillation Division, Inc. Non-contact electrode basket catheters with irrigation
US8712550B2 (en) 2008-12-30 2014-04-29 Biosense Webster, Inc. Catheter with multiple electrode assemblies for use at or near tubular regions of the heart
US8271099B1 (en) 2009-03-23 2012-09-18 Advanced Neuromodulation Systems, Inc. Implantable paddle lead comprising compressive longitudinal members for supporting electrodes and method of fabrication
US8167845B2 (en) 2009-06-02 2012-05-01 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter having distal sealing member
US8280477B2 (en) 2009-07-29 2012-10-02 Medtronic Cryocath Lp Mono-phasic action potential electrogram recording catheter, and method
AU2010319333B2 (en) 2009-11-13 2014-02-20 St. Jude Medical, Inc. Assembly of staggered ablation elements
US20110245756A1 (en) 2009-12-03 2011-10-06 Rishi Arora Devices for material delivery, electroporation, sonoporation, and/or monitoring electrophysiological activity
US9616199B2 (en) 2009-12-31 2017-04-11 St. Jude Medical, Atrial Fibrillation Division, Inc. Irrigated catheter employing multi-lumenal irrigation tubing
US20120130217A1 (en) 2010-11-23 2012-05-24 Kauphusman James V Medical devices having electrodes mounted thereon and methods of manufacturing therefor
JP6078471B2 (en) 2010-11-19 2017-02-08 セント・ジュード・メディカル・エイトリアル・フィブリレーション・ディヴィジョン・インコーポレーテッド Electrode catheter device with indifferent electrode for direct current tissue treatment
US20120130218A1 (en) 2010-11-23 2012-05-24 Kauphusman James V Medical devices having an electroanatomical system imaging element mounted thereon
US8560086B2 (en) 2010-12-02 2013-10-15 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter electrode assemblies and methods of construction therefor
US8391947B2 (en) 2010-12-30 2013-03-05 Biosense Webster (Israel), Ltd. Catheter with sheet array of electrodes
US9186081B2 (en) 2010-12-30 2015-11-17 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for diagnosing arrhythmias and directing catheter therapies
US9044245B2 (en) 2011-01-05 2015-06-02 Medtronic Ablation Frontiers Llc Multipolarity epicardial radiofrequency ablation
US9486273B2 (en) 2011-01-21 2016-11-08 Kardium Inc. High-density electrode-based medical device system
CA2764494A1 (en) 2011-01-21 2012-07-21 Kardium Inc. Enhanced medical device for use in bodily cavities, for example an atrium
WO2012145072A1 (en) 2011-04-22 2012-10-26 Topera, Inc. Basket style cardiac mapping catheter having a flexible electrode assembly for detection of cardiac rhythm disorders
US20120296232A1 (en) 2011-05-18 2012-11-22 St. Jude Medical, Inc. Method and apparatus of assessing transvascular denervation
US10743932B2 (en) 2011-07-28 2020-08-18 Biosense Webster (Israel) Ltd. Integrated ablation system using catheter with multiple irrigation lumens
US20130030430A1 (en) 2011-07-29 2013-01-31 Stewart Mark T Intracardiac tools and methods for delivery of electroporation therapies
KR101497458B1 (en) 2011-08-25 2015-03-02 코비디엔 엘피 Systems, devices, and methods for treatment of luminal tissue
US9277960B2 (en) 2011-09-08 2016-03-08 Kardium Inc. Intra-cardiac mapping and ablating
US8498686B2 (en) 2011-10-04 2013-07-30 Biosense Webster (Israel), Ltd. Mapping catheter with spiral electrode assembly
WO2013052852A1 (en) 2011-10-07 2013-04-11 Boston Scientific Scimed, Inc. Methods and systems for detection and thermal treatment of lower urinary tract conditions
EP2765940B1 (en) 2011-10-11 2015-08-26 Boston Scientific Scimed, Inc. Off-wall electrode device for nerve modulation
US20140350553A1 (en) 2011-11-21 2014-11-27 Denerve Inc. Renal artery ablation catheter and system
US9131980B2 (en) 2011-12-19 2015-09-15 Medtronic Advanced Energy Llc Electrosurgical devices
EP2797534A1 (en) 2011-12-28 2014-11-05 Boston Scientific Scimed, Inc. Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
US8956353B2 (en) 2011-12-29 2015-02-17 Biosense Webster (Israel) Ltd. Electrode irrigation using micro-jets
US8825130B2 (en) 2011-12-30 2014-09-02 St. Jude Medical, Atrial Fibrillation Division, Inc. Electrode support structure assemblies
US9314299B2 (en) 2012-03-21 2016-04-19 Biosense Webster (Israel) Ltd. Flower catheter for mapping and ablating veinous and other tubular locations
CN104582619B (en) 2012-04-26 2018-12-04 麦德托尼克消融前沿有限公司 System for organizing contact during detecting ablation
WO2013166292A1 (en) 2012-05-02 2013-11-07 The Charlotte-Mecklenburg Hospital Authority D/ B/ A Carolinas Healthcare System Devices, systems, and methods for treating cardiac arrhythmias
US20140207136A1 (en) 2012-05-04 2014-07-24 St. Jude Medical, Inc. Multiple staggered electrodes connected via flexible joints
US9011423B2 (en) 2012-05-21 2015-04-21 Kardium, Inc. Systems and methods for selecting, activating, or selecting and activating transducers
EP2874555A1 (en) 2012-07-17 2015-05-27 Boston Scientific Scimed, Inc. Renal nerve modulation catheter design
US10314649B2 (en) 2012-08-02 2019-06-11 Ethicon Endo-Surgery, Inc. Flexible expandable electrode and method of intraluminal delivery of pulsed power
US9801681B2 (en) 2012-08-17 2017-10-31 Medtronic Ablation Frontiers Llc Catheters and methods for intracardiac electrical mapping
EP2890292B1 (en) 2012-08-31 2021-01-13 Acutus Medical, Inc. Catheter system for the heart
US9833608B2 (en) 2012-11-20 2017-12-05 NeuroTronik IP Holding (Jersey) Limited Positioning methods for intravascular electrode arrays for neuromodulation
US20140316496A1 (en) 2012-11-21 2014-10-23 NeuroTronik IP Holding (Jersey) Limited Intravascular Electrode Arrays for Neuromodulation
US20140180147A1 (en) 2012-12-20 2014-06-26 Boston Scientific Scimed, Inc. Estimating interspline distances on mapping catheters
US9681817B2 (en) 2012-12-20 2017-06-20 Boston Scientific Scimed, Inc. Suppression of global activation signals during anatomical mapping
EP2934288A1 (en) 2012-12-20 2015-10-28 Boston Scientific Scimed, Inc. Real-time feedback for electrode contact during mapping
US10537286B2 (en) 2013-01-08 2020-01-21 Biosense Webster (Israel) Ltd. Catheter with multiple spines of different lengths arranged in one or more distal assemblies
US20140200639A1 (en) 2013-01-16 2014-07-17 Advanced Neuromodulation Systems, Inc. Self-expanding neurostimulation leads having broad multi-electrode arrays
CN108209986B (en) 2013-02-08 2020-11-10 阿库图森医疗有限公司 Expandable catheter assembly with flexible printed circuit board
US9474486B2 (en) 2013-03-08 2016-10-25 St. Jude Medical, Atrial Fibrillation Division, Inc. Basket for a multi-electrode array catheter
WO2014165062A1 (en) 2013-03-13 2014-10-09 Kardium, Inc. Detecting improper energy transmission configuration in medical device system
US9345540B2 (en) 2013-03-15 2016-05-24 Medtronic Ablation Frontiers Llc Contact specific RF therapy balloon
US10602947B2 (en) 2013-04-11 2020-03-31 Biosense Webster (Israel), Ltd. High density electrode structure
US10575743B2 (en) 2013-04-11 2020-03-03 Biosense Webster (Israel) Ltd. High electrode density basket catheter
US20140316294A1 (en) 2013-04-22 2014-10-23 Boston Scientific Scimed, Inc. Method and apparatus for suppressing far-field sensing during atrial mapping
EP2988691B1 (en) 2013-04-25 2018-03-28 St. Jude Medical, Cardiology Division, Inc. Electrode assembly for catheter system
US20160113709A1 (en) 2013-06-05 2016-04-28 Tel Hashomer Medical Research Infrastructure And Services Ltd Myocardial ablation by irreversible electroporation
US9814618B2 (en) 2013-06-06 2017-11-14 Boston Scientific Scimed, Inc. Devices for delivering energy and related methods of use
US20150011991A1 (en) 2013-07-03 2015-01-08 St. Jude Medical, Cardiology Division, Inc. Electrode Assembly For Catheter System
US20150045863A1 (en) 2013-08-07 2015-02-12 Boston Scientific Scimed, Inc. Expandable electrodes and methods for treating tissues
US9204929B2 (en) 2013-09-16 2015-12-08 Biosense Webster (Israel) Ltd. Basket catheter with deflectable spine
US10687889B2 (en) 2013-10-11 2020-06-23 Biosense Webster (Israel) Ltd. Patient-specific pre-shaped cardiac catheter
US9687166B2 (en) 2013-10-14 2017-06-27 Boston Scientific Scimed, Inc. High resolution cardiac mapping electrode array catheter
US20150119878A1 (en) 2013-10-24 2015-04-30 St. Jude Medical, Cardiology Division, Inc. Electrode assembly having asymmetric electrode placement
US11051877B2 (en) 2013-11-07 2021-07-06 St. Jude Medical, Cardiology Division, Inc. Medical device with contact force sensing tip
JP6625980B2 (en) 2013-11-29 2019-12-25 キャスアールエックス リミテッドCathrx Ltd Basket catheter and method of manufacturing the same
US10314648B2 (en) 2013-12-13 2019-06-11 The Trustees of the Universoty of Pennsylvania Coaxial ablation probe and method and system for real-time monitoring of ablation therapy
EP3498156B1 (en) 2013-12-20 2024-06-12 St. Jude Medical, Cardiology Division, Inc. Coaxial electrode catheters for extracting electrophysiologic parameters
US9993160B2 (en) 2014-01-07 2018-06-12 Kardium Inc. Medical device including manipulable portion with connected elongate members
US9480416B2 (en) 2014-01-17 2016-11-01 Biosense Webster (Israel) Ltd. Signal transmission using catheter braid wires
US9554718B2 (en) 2014-01-29 2017-01-31 Biosense Webster (Israel) Ltd. Double bipolar configuration for atrial fibrillation annotation
US9907609B2 (en) 2014-02-04 2018-03-06 Boston Scientific Scimed, Inc. Alternative placement of thermal sensors on bipolar electrode
US9750422B2 (en) 2014-02-12 2017-09-05 Biosense Webster (Israel) Ltd Catheter with transverse branches
CN105960200B (en) * 2014-02-25 2019-08-30 圣犹达医疗用品心脏病学部门有限公司 Systems and methods for classifying arrhythmia sources using electrophysiological properties
US9986949B2 (en) 2014-03-05 2018-06-05 Biosense Webster (Israel) Ltd. Multi-arm catheter with signal transmission over braid wires
US20150254893A1 (en) 2014-03-06 2015-09-10 Boston Scientific Scimed, Inc. Medical devices for mapping cardiac tissue and methods for displaying mapping data
US20150270634A1 (en) 2014-03-21 2015-09-24 St. Jude Medical, Cardiology Division, Inc. Electrode assembly for catheter system including struts having a non-uniform thickness
WO2015171418A2 (en) 2014-05-06 2015-11-12 St. Jude Medical, Cardiology Division, Inc. Electrode support structure assembly
WO2015187386A1 (en) 2014-06-03 2015-12-10 Boston Scientific Scimed, Inc. Electrode assembly having an atraumatic distal tip
EP3151773B1 (en) 2014-06-04 2018-04-04 Boston Scientific Scimed, Inc. Electrode assembly
US9498142B2 (en) 2014-07-03 2016-11-22 Heraeus Deutschland GmbH & Co. KG Multi-layered structure and method
CN104257427A (en) 2014-08-05 2015-01-07 上海魅丽纬叶医疗科技有限公司 Radiofrequency ablation catheter with segment-shaped support structure and equipment thereof
ES2529702B1 (en) 2014-09-12 2015-09-29 Universitat Politècnica De València Catheter and method for detecting electrical activity in an organ
EP3191164A4 (en) 2014-09-12 2018-08-15 X-Rhythm, LLC Multi-electrode mapping catheter
WO2016044687A1 (en) 2014-09-18 2016-03-24 University Of Utah Research Foundation Cardiac mapping catheter
WO2016065464A1 (en) 2014-10-30 2016-05-06 Kardium Inc. Catheter system
US9788893B2 (en) 2014-11-20 2017-10-17 Biosense Webster (Israel) Ltd. Catheter with soft distal tip for mapping and ablating tubular region
US9782099B2 (en) 2014-12-31 2017-10-10 Biosense Webster (Israel) Ltd. Basket catheter with improved spine flexibility
US9801585B2 (en) 2014-12-31 2017-10-31 Biosense Webster (Israel) Ltd. Electrocardiogram noise reduction
EP3209235B1 (en) 2015-01-28 2019-06-26 St. Jude Medical, Cardiology Division, Inc. Thermal mapping catheter
US9833161B2 (en) 2015-02-09 2017-12-05 Biosense Webster (Israel) Ltd. Basket catheter with far-field electrode
CN107223034B (en) 2015-02-20 2020-12-11 波士顿科学医学有限公司 Tissue Contact Sensing Using Medical Devices
WO2016168778A1 (en) 2015-04-17 2016-10-20 Boston Scientific Scimed Inc. Tissue diagnosis and treatment using electrodes and mini-electrodes
WO2016176009A1 (en) 2015-04-30 2016-11-03 The Regents Of The University Of Michigan Method and system for mapping and analyzing cardiac electrical activity
US20160338770A1 (en) 2015-05-19 2016-11-24 Biosense Webster (Israel) Ltd. Woven foldable catheter
US9949656B2 (en) 2015-06-29 2018-04-24 Biosense Webster (Israel) Ltd. Catheter with stacked spine electrode assembly
US10537259B2 (en) * 2015-06-29 2020-01-21 Biosense Webster (Israel) Ltd. Catheter having closed loop array with in-plane linear electrode portion
US10575742B2 (en) 2015-06-30 2020-03-03 Biosense Webster (Israel) Ltd. Catheter having closed electrode assembly with spines of uniform length
US9895073B2 (en) 2015-07-29 2018-02-20 Biosense Webster (Israel) Ltd. Dual basket catheter
EP3331464B1 (en) 2015-08-03 2025-10-29 Boston Scientific Scimed, Inc. Steerable tissue mapping and ablation device
US20190117303A1 (en) 2015-08-06 2019-04-25 Apama Medical, Inc. Multipurpose electrode
US10492857B2 (en) 2015-08-06 2019-12-03 Boston Scientific Scimed Inc Deployment control apparatus for a catheter with a deployable array
US10376170B2 (en) 2015-08-10 2019-08-13 Boston Scientific Scimed, Inc. Catheter with annular lumen to provide distal flushing
US10758144B2 (en) 2015-08-20 2020-09-01 Boston Scientific Scimed Inc. Flexible electrode for cardiac sensing and method for making
US20170071543A1 (en) 2015-09-14 2017-03-16 Biosense Webster (Israel) Ltd. Convertible basket catheter
US10357173B2 (en) 2015-09-14 2019-07-23 Biosense Webster (Israel) Ltd. Dual multiray electrode catheter
US10987045B2 (en) 2015-09-14 2021-04-27 Biosense Webster (Israel) Ltd. Basket catheter with individual spine control
US10130420B2 (en) 2015-10-08 2018-11-20 Biosense Webster (Israel) Ltd. Catheter with membraned spines for pulmonary vein isolation
EP4205685B1 (en) 2015-10-21 2024-08-28 St. Jude Medical, Cardiology Division, Inc. High density electrode mapping catheter
CN108882884B (en) 2015-10-21 2022-05-31 奥托诺米克斯医药有限公司 Controlled and precise treatment of cardiac tissue
JP6445742B1 (en) 2015-10-21 2018-12-26 セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド High density electrode mapping catheter
US10758304B2 (en) 2015-12-07 2020-09-01 Biosense Webster (Israel) Ltd. Basket catheter with an improved seal
US9894756B2 (en) 2015-12-08 2018-02-13 Kardium Inc. Circuits for flexible structures
US10362952B2 (en) 2015-12-10 2019-07-30 Biosense Webster (Israel) Ltd. Stabilized spine electrophysiologic catheter
US10687761B2 (en) 2015-12-23 2020-06-23 Biosense Webster (Israel) Ltd. Catheter frame pieces used as large single axis sensors
US10078713B2 (en) 2015-12-24 2018-09-18 Biosense Webster (Israel) Ltd. Global mapping catheter contact optimization
WO2020206328A1 (en) 2019-04-04 2020-10-08 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10660702B2 (en) 2016-01-05 2020-05-26 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10130423B1 (en) 2017-07-06 2018-11-20 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10172673B2 (en) 2016-01-05 2019-01-08 Farapulse, Inc. Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10582894B2 (en) 2016-01-14 2020-03-10 Biosense Webster (Israel) Ltd. Region of interest rotational activity pattern detection
US9907480B2 (en) 2016-02-08 2018-03-06 Biosense Webster (Israel) Ltd. Catheter spine assembly with closely-spaced bipole microelectrodes
SG11201807446UA (en) 2016-03-09 2018-09-27 Cardionomic Inc Cardiac contractility neurostimulation systems and methods
US10314505B2 (en) 2016-03-15 2019-06-11 Biosense Webster (Israel) Ltd. Asymmetric basket catheter
US10285610B2 (en) 2016-03-23 2019-05-14 Biosense Webster (Israel) Ltd. Dispersed irrigation configuration for catheter tip design
US10136828B2 (en) 2016-03-31 2018-11-27 Biosense Webster (Israel) Ltd. Mapping of atrial fibrillation
US10362991B2 (en) 2016-04-04 2019-07-30 Biosense Webster (Israel) Ltd. Convertible basket catheter
US20170296251A1 (en) 2016-04-13 2017-10-19 Biosense Webster (Israel) Ltd. Basket catheter with prestrained framework
EP3238645A1 (en) 2016-04-15 2017-11-01 Cook Medical Technologies LLC Ablation medical device with basket
US10660700B2 (en) 2016-04-28 2020-05-26 Biosense Webster (Israel) Ltd. Irrigated balloon catheter with flexible circuit electrode assembly
JP7064447B2 (en) 2016-05-02 2022-05-10 アフェラ, インコーポレイテッド Catheter with ablation electrodes and image sensors, and methods for image-based ablation
JP6528010B1 (en) 2016-05-03 2019-06-12 セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド Irrigation type high density electrode catheter
US9974460B2 (en) 2016-05-06 2018-05-22 Biosense Webster (Israel) Ltd. Basket-shaped catheter with improved distal hub
US10772566B2 (en) 2016-05-17 2020-09-15 Biosense Weber (Israel) Ltd. Multi-electrode catheter spine and method of making the same
US10898139B2 (en) 2016-06-03 2021-01-26 Biosense Webster (Israel) Ltd. Spine construction for basket catheter
US10905329B2 (en) 2016-06-09 2021-02-02 Biosense Webster (Israel) Ltd. Multi-function conducting elements for a catheter
US20170354338A1 (en) 2016-06-09 2017-12-14 Biosense Webster (Israel) Ltd. Dual-function sensors for a basket catheter
US10349855B2 (en) 2016-06-10 2019-07-16 Biosense Webster (Israel) Ltd. Identification and visualization of cardiac activation sequence in multi-channel recordings
WO2017223264A1 (en) 2016-06-23 2017-12-28 St. Jude Medical, Cardiology Division, Inc. Catheter system and electrode assembly for intraprocedural evaluation of renal denervation
US10376221B2 (en) 2016-07-06 2019-08-13 Biosense Webster (Israel) Ltd. Automatic creation of multiple electroanatomic maps
US20190298442A1 (en) 2016-07-11 2019-10-03 Retrovascular, Inc. Bi-polar tissue ablation device and methods of use thereof
WO2018039225A1 (en) 2016-08-24 2018-03-01 Boston Scientific Scimed, Inc. Catheter system and a system for treating endometriosis
US10702177B2 (en) 2016-08-24 2020-07-07 Biosense Webster (Israel) Ltd. Catheter with bipole electrode spacer and related methods
US11559349B2 (en) 2016-09-12 2023-01-24 Biosense Webster (Israel) Ltd. Ablation catheter with a flexible printed circuit board
US20180085064A1 (en) 2016-09-29 2018-03-29 Biosense Webster (Israel) Ltd. Basket catheter conforming to organ using strain-relief elements
US11172858B2 (en) * 2016-10-28 2021-11-16 St. Jude Medical, Cardiology Division, Inc. Flexible high-density mapping catheter
US10314507B2 (en) 2016-11-14 2019-06-11 Biosense Webster (Israel) Ltd. ASIC with switching noise reduction
US10403053B2 (en) 2016-11-15 2019-09-03 Biosense Webster (Israel) Ltd. Marking sparse areas on maps
US11129574B2 (en) 2016-12-12 2021-09-28 Biosense Webster (Israel) Ltd. Real time electroanatomical coloring of the heart
US10918306B2 (en) 2016-12-13 2021-02-16 Biosense Webster (Israel) Ltd. Catheter splines with embedded circuit elements
WO2018111600A1 (en) 2016-12-15 2018-06-21 St. Jude Medical, Cardiology Division, Inc. Pulmonary vein isolation balloon catheter
WO2018118798A1 (en) 2016-12-19 2018-06-28 Boston Scientific Scimed Inc. Distally-facing electrode array with longitudinally mounted splines
WO2018129133A1 (en) 2017-01-06 2018-07-12 St. Jude Medical, Cardiology Division, Inc. Pulmonary vein isolation balloon catheter
US20180192958A1 (en) 2017-01-06 2018-07-12 Biosense Webster (Israel) Ltd. Multi-electrode assembly with controlled folding mechanism
US11246534B2 (en) 2017-01-23 2022-02-15 Biosense Webster (Israel) Ltd. Basket catheter made from flexible circuit board with mechanical strengthening
WO2018144765A1 (en) 2017-02-01 2018-08-09 The George Washington University High resolution multi-function and conformal electronics device for diagnosis and treatment of cardiac arrhythmias
DE102017001971A1 (en) 2017-03-01 2018-09-06 Peter Osypka Stiftung Stiftung des bürgerlichen Rechts Multi-electrode array
US11116450B2 (en) 2017-03-09 2021-09-14 Biosense Webster (Israel) Ltd. Electrode assembly having spines with controlled flexibility
US10014607B1 (en) 2017-03-13 2018-07-03 Bionsense Webster (Israel) Ltd. PCB sub-connectors
US10765371B2 (en) 2017-03-31 2020-09-08 Biosense Webster (Israel) Ltd. Method to project a two dimensional image/photo onto a 3D reconstruction, such as an epicardial view of heart
EP4382160A3 (en) 2017-04-10 2024-08-14 St. Jude Medical, Cardiology Division, Inc. Electroporation system and method of energizing a catheter
WO2018187856A1 (en) 2017-04-12 2018-10-18 Kardium Inc. Medical device systems and methods including helically configured or twisted, non-helically configured elongate members
US20180310987A1 (en) 2017-04-27 2018-11-01 Biosense Webster (Israel) Ltd. Systems and processes for map-guided automatic cardiac ablation
US10617867B2 (en) 2017-04-28 2020-04-14 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue
US12029545B2 (en) 2017-05-30 2024-07-09 Biosense Webster (Israel) Ltd. Catheter splines as location sensors
US11801082B2 (en) 2017-06-05 2023-10-31 St. Jude Medical, Cardiology Division, Inc. Balloon-in-basket ablation catheter
WO2018226761A1 (en) 2017-06-06 2018-12-13 Cardiac Pacemakers, Inc. Ablation delivery using a catheter having a semi-permeable inflatable balloon structure
US20180360534A1 (en) 2017-06-19 2018-12-20 St. Jude Medical, Cardiology Division, Inc. Apparatuses and methods for high-density sensing and ablation during a medical procedure
US10952795B2 (en) 2017-06-30 2021-03-23 Biosense Webster (Israel) Ltd. System and method for glass state view in real-time three-dimensional (3D) cardiac imaging
US11666379B2 (en) 2017-07-06 2023-06-06 Biosense Webster (Israel) Ltd. Temperature controlled short duration ablation with multiple electrodes
US11109788B2 (en) 2017-07-17 2021-09-07 Biosense Webster (Israel) Ltd. Catheter with Fibonacci distributed electrodes
US11052246B2 (en) 2017-07-28 2021-07-06 Medtronic, Inc. Expandable elements for delivery of electric fields
US11304603B2 (en) 2017-08-21 2022-04-19 Biosense Webster (Israel) Ltd. Advanced current location (ACL) automatic map rotation to detect holes in current position map (CPM) mapping
US10682181B2 (en) 2017-09-06 2020-06-16 Biosense Webster (Israel) Ltd. Methods and systems for modeling and registration of 3-dimensional images of the heart
US10441188B2 (en) 2017-09-12 2019-10-15 Biosense Webster (Israel) Ltd. Automatic display of earliest LAT point
CN115844523A (en) 2017-09-12 2023-03-28 波士顿科学医学有限公司 Systems, devices, and methods for ventricular focal ablation
US10702178B2 (en) 2017-10-13 2020-07-07 St. Jude Medical, Cardiology Division, Inc. Catheter with high-density mapping electrodes
WO2019075459A1 (en) 2017-10-13 2019-04-18 Mayo Foundation For Medical Education And Research Methods and devices for electroporation for treatment of ventricular fibrillation
US10398348B2 (en) 2017-10-19 2019-09-03 Biosense Webster (Israel) Ltd. Baseline impedance maps for tissue proximity indications
US10959784B2 (en) 2017-10-24 2021-03-30 Biosense Webster (Israel) Ltd. Determining balloon catheter contact with anatomy using ultrasound
EP3668395B1 (en) 2017-10-26 2023-10-11 Boston Scientific Scimed Inc. Use of electromagnetic fields in ire device delivery and therapy monitoring
WO2019084442A1 (en) 2017-10-27 2019-05-02 St. Jude Medical, Cardiology Division, Inc. Pulmonary vein isolation balloon catheter
US10881376B2 (en) 2017-11-08 2021-01-05 Biosense Webster (Israel) Ltd. System and method for providing auditory guidance in medical systems
US11295835B2 (en) 2017-11-27 2022-04-05 Biosense Webster (Israel) Ltd. System and method for interactive event timeline
US11164371B2 (en) 2017-12-20 2021-11-02 Biosense Webster (Israel) Ltd. Marking a computerized model of a cardiac surface
JP2021508533A (en) 2017-12-26 2021-03-11 ギャラリー,インコーポレイテッド Optimizing energy delivery for a variety of applications
US11517715B2 (en) 2018-01-02 2022-12-06 Biosense Webster (Israel) Ltd. Deflectable medical probe
US10973461B2 (en) 2018-01-10 2021-04-13 Biosense Webster (Israel) Ltd. Mapping of intra-body cavity using a distributed ultrasound array on basket catheter
US11147496B2 (en) 2018-01-16 2021-10-19 Boston Scientific Scimed Inc. Systems and methods for mapping electrical activity in the heart
US20190216347A1 (en) 2018-01-16 2019-07-18 Boston Scientific Scimed Inc. Systems and methods for activation mapping of the heart without the use of a reference catheter
EP3740148A1 (en) 2018-01-18 2020-11-25 Farapulse, Inc. Systems, devices, and methods for focal ablation
CN117958829A (en) 2018-03-13 2024-05-03 圣犹达医疗用品心脏病学部门有限公司 Variable density mapping catheter
US20190314083A1 (en) 2018-04-11 2019-10-17 Biosense Webster (Israel) Ltd. Flexible Multi-Arm Catheter with Diametrically Opposed Sensing Electrodes
EP3768185B1 (en) 2018-05-21 2023-06-14 St. Jude Medical, Cardiology Division, Inc. Radio-frequency ablation and direct current electroporation catheters
US11642165B2 (en) 2018-06-29 2023-05-09 Biosense Webster (Israel) Ltd. Catheter with mechanically expandable element having flex circuit
US10912484B2 (en) 2018-07-09 2021-02-09 Biosense Webster (Israel) Ltd. Multiplexing of high count electrode catheter(s)
US12440166B2 (en) 2018-07-20 2025-10-14 Kardium Inc. Systems and methods for facilitating improved transducer-to-tissue contact
US11690551B2 (en) 2018-07-30 2023-07-04 Biosense Webster (Israel) Ltd. Left atrium shape reconstruction from sparse location measurements using neural networks
JP2020018606A (en) 2018-08-01 2020-02-06 テルモ株式会社 Medical device
US20200038101A1 (en) 2018-08-03 2020-02-06 Biosense Webster (Israel) Ltd. Unipolar reference electrode for electrophysiology mapping catheter
US11241281B2 (en) 2018-08-13 2022-02-08 Biosense Webster (Israel) Ltd. Estimation of electrode-tissue contact using oscillator at common ground of electrocardiogram (ECG) system
WO2020039392A2 (en) 2018-08-23 2020-02-27 St. Jude Medical, Cardiology Division, Inc. Curved high density electrode mapping catheter
WO2020061359A1 (en) 2018-09-20 2020-03-26 Farapulse, Inc. Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US11452484B2 (en) 2018-10-25 2022-09-27 Biosense Webster (Israel) Ltd. Electrodes on double-sided printed circuit board (PCB) to cancel far-held signal
US11596324B2 (en) 2018-10-25 2023-03-07 Biosense Webster (Israel) Ltd. Combined active current location (ACL) and tissue proximity indication (TPI) system
US11660050B2 (en) 2018-10-25 2023-05-30 Biosense Webster (Israel) Ltd Balloon catheter with diagnostic electrodes, far field electrodes, and guidewire
US11045628B2 (en) 2018-12-11 2021-06-29 Biosense Webster (Israel) Ltd. Balloon catheter with high articulation
US20200205737A1 (en) 2018-12-28 2020-07-02 Biosense Webster (Israel) Ltd. Flexible Nested Sensing Electrodes
US11826088B2 (en) 2018-12-28 2023-11-28 Biosense Webster (Israel) Ltd. Adjusting phases of multiphase ablation generator to detect contact
US11207016B2 (en) 2018-12-28 2021-12-28 Biosense Webster (Israel) Ltd. Mapping ECG signals using a multipole electrode assembly
EP4417119A3 (en) 2019-03-18 2024-11-20 Biosense Webster (Israel) Ltd. Electrode configurations for diagnosis of arrhythmias
US11850051B2 (en) 2019-04-30 2023-12-26 Biosense Webster (Israel) Ltd. Mapping grid with high density electrode array
US20210015549A1 (en) 2019-05-29 2021-01-21 Sirona Medical Technologies, Inc. Ablation lesion quality
US11504042B2 (en) 2019-06-19 2022-11-22 Biosense Webster (Israel) Ltd. Extension of electrocardiography (ECG) acquisition capabilities of catheter-based cardiac system
US11540878B2 (en) 2019-07-17 2023-01-03 Biosense Webster (Israel) Ltd. Blooming leaflet catheter with high density electrode array
US11712172B2 (en) 2019-07-18 2023-08-01 Biosense Webster (Israel) Ltd. Visual guidance for positioning a distal end of a medical probe
US11259751B2 (en) 2019-07-22 2022-03-01 Biosense Webster (Isreal) Ltd. Recording apparatus and method for noise reduction
US12114918B2 (en) 2019-08-15 2024-10-15 Biosense Webster (Israel) Ltd. Dynamic ablation and sensing according to contact of segmented electrodes
US20210059549A1 (en) 2019-08-26 2021-03-04 Biosense Webster (Israel) Ltd. Error estimation of local activation times (lat) measured by multiple electrode catheter
US11116435B2 (en) 2019-08-26 2021-09-14 Biosense Webster (Israel) Ltd. Automatic identification of a location of focal source in atrial fibrillation (AF)
US11759150B2 (en) 2019-08-27 2023-09-19 Biosense Webster (Israel) Ltd. Accurate basket catheter tracking
US20210059743A1 (en) 2019-08-27 2021-03-04 Biosense Webster (Israel) Ltd. Estimation of Electrode-Tissue Contact Using Stem and Edge Electrodes
US12016621B2 (en) 2019-08-29 2024-06-25 St. Jude Medical, Cardiology Division, Inc. Force sensing catheter sealed electrode tip assembly and methods of assembling same
US12178500B2 (en) 2019-09-03 2024-12-31 Biosense Webster (Israel) Ltd. Mapping catheter with flex panel electrode assembly
US20210082157A1 (en) 2019-09-12 2021-03-18 Biosense Webster (Israel) Ltd. Graphical user interface for an ablation system
US20210077184A1 (en) 2019-09-16 2021-03-18 Biosense Webster (Israel) Ltd. Catheter with thin-film electrodes on expandable membrane
US20210085387A1 (en) 2019-09-22 2021-03-25 Biosense Webster (Israel) Ltd. Guiding cardiac ablation using machine learning (ml)
US20210085215A1 (en) 2019-09-22 2021-03-25 Biosense Webster (Israel) Ltd. Ecg-based cardiac wall thickness estimation
US12285258B2 (en) 2019-09-24 2025-04-29 Biosense Webster (Israel) Ltd. 3D intracardiac activity presentation
US11432754B2 (en) 2019-09-24 2022-09-06 Biosense Webster (Israel) Ltd. Intracardiac electrocardiogram presentation
US12186010B2 (en) 2019-09-26 2025-01-07 Biosense Webster (Israel) Ltd. Wiring for multi-electrode catheter
US11937975B2 (en) 2019-09-30 2024-03-26 Biosense Webster (Israel) Ltd. Multi-frequency mapping catheter and method of mapping
US11633229B2 (en) 2019-10-07 2023-04-25 Biosense Webster (Israel) Ltd. 3D electrical activity representation
US11366991B2 (en) 2019-11-05 2022-06-21 Biosense Webster (Israel) Ltd Optimizing mapping of ECG signals retrospectively by detecting inconsistency
US12262999B2 (en) 2019-11-05 2025-04-01 Biosense Webster (Israel) Ltd. Using statistical characteristics of multiple grouped ECG signals to detect inconsistent signals
US11931182B2 (en) 2019-12-09 2024-03-19 Biosense Webster (Israel) Ltd. Catheter with plurality of sensing electrodes used as ablation electrode
US20210169568A1 (en) 2019-12-09 2021-06-10 Biosense Webster (Israel) Ltd. Oriented irreversible-electroporation (ire) pulses to compensate for cell size and orientation
US12042216B2 (en) 2019-12-09 2024-07-23 Biosense Webster (Israel) Ltd. Irreversible-electroporation (IRE) balloon catheter with membrane-insulated high-voltage balloon wires
US11950930B2 (en) 2019-12-12 2024-04-09 Biosense Webster (Israel) Ltd. Multi-dimensional acquisition of bipolar signals from a catheter
US11684302B2 (en) 2019-12-13 2023-06-27 Biosense Webster (Israel) Ltd. Automated graphical presentation of electrophysiological parameters
US11040208B1 (en) 2019-12-17 2021-06-22 Biosense Webster (Israel) Ltd. Distributed cardiac pacing system
US20220054192A1 (en) 2019-12-20 2022-02-24 Biosense Webster (Israel) Ltd. Devices and methods for an expandable assembly catheter
US12029862B2 (en) 2019-12-20 2024-07-09 Biosense Webster (Israel) Ltd. Expandable assembly catheter
US11517218B2 (en) 2019-12-20 2022-12-06 Biosense Webster (Israel) Ltd. Selective graphical presentation of electrophysiological parameters
US11006902B1 (en) 2019-12-23 2021-05-18 Biosense Webster (Israel) Ltd. GUI for selective operation of multi-electrode catheters
US11484367B2 (en) 2019-12-27 2022-11-01 Biosense Webster (Israel) Ltd. Device and method of determining location of sheath using electromagnetic sensors on sheath
US20210196372A1 (en) 2019-12-31 2021-07-01 Biosense Webster (Israel) Ltd. Using irrigation on irreversible-electroporation (ire) electrodes to prevent arcing
US11730414B2 (en) 2020-01-21 2023-08-22 Biosense Webster (Israel) Ltd. Automatic pattern acquisition
US20210278936A1 (en) 2020-03-09 2021-09-09 Biosense Webster (Israel) Ltd. Electrophysiological user interface
US11497427B2 (en) 2020-03-12 2022-11-15 Biosense Webster (Israel) Ltd. Adjusting annotation points in real time
US20210307815A1 (en) 2020-04-07 2021-10-07 Biosense Webster (Israel) Ltd. Basket Catheter with Solid Conducting Spines as Electrodes for IRE
US11553961B2 (en) 2020-04-30 2023-01-17 Biosense Webster (Israel) Ltd. Catheter with stretchable irrigation tube
US12232874B2 (en) 2020-05-29 2025-02-25 Biosense Webster (Israel) Ltd. Electrode apparatus for diagnosis of arrhythmias
CN113796868A (en) 2020-05-29 2021-12-17 伯恩森斯韦伯斯特(以色列)有限责任公司 Intraluminal reference electrode for cardiovascular therapy device
EP4167886B1 (en) 2020-08-18 2024-05-01 St. Jude Medical, Cardiology Division, Inc. High-density electrode catheters with magnetic position tracking
CA3244179A1 (en) 2021-12-21 2023-06-29 Coremap Inc Devices and methods for tissue mapping

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060253117A1 (en) * 1992-01-07 2006-11-09 Arthrocare Corporation Systems and methods for electrosurgical treatment of obstructive sleep disorders
US20010001314A1 (en) * 1997-06-13 2001-05-17 Arthrocare Corporation Electrosurgical systems and methods for recanalization of occluded body lumens
US20030236455A1 (en) * 2000-10-05 2003-12-25 Scimed Life Systems, Inc. Probe assembly for mapping and ablating pulmonary vein tissue and method of using same
US20130226167A1 (en) * 2004-11-05 2013-08-29 Asthmatx, Inc. Energy delivery devices and methods
US20140018788A1 (en) * 2012-07-04 2014-01-16 Zoar Jacob ENGELMAN Devices and Systems for Carotid Body Ablation
US20160073913A1 (en) * 2013-04-22 2016-03-17 Imperial Innovations Limited Image display interfaces
US20160346038A1 (en) * 2014-02-06 2016-12-01 St. Jude Medical, Cardiology Division, Inc. Elongate medical device including chamfered ring electrode and variable shaft
US20170296125A1 (en) * 2014-10-28 2017-10-19 Biosense Webster (Israel) Ltd. Basket catheter with microelectrode array distal tip
US20160143588A1 (en) * 2014-11-20 2016-05-26 Biosense Webster (Israel) Ltd. Catheter with high density electrode spine array
US20170007158A1 (en) * 2015-07-08 2017-01-12 Rainbow Medical Ltd. Hemodynamic-signal-based electrode-tissue contact detection
US20180185651A1 (en) * 2017-01-05 2018-07-05 Medtronic Bakken Research Center B.V. Impedance-based allocation of electrical stimulation to electrode clusters
US20200196893A1 (en) * 2018-02-05 2020-06-25 Mayo Foundation For Medical Education And Research Systems and methods for mapping and modulating repolarization

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12350050B2 (en) * 2014-04-14 2025-07-08 Recor Medical, Inc. Intraluminal microneurography probes and related systems and methods
US12263014B2 (en) 2020-08-18 2025-04-01 St. Jude Medical, Cardiology Division, Inc. High-density electrode catheters with magnetic position tracking
EP4115833A1 (en) 2021-07-09 2023-01-11 Biosense Webster (Israel) Ltd. Ablation and mapping with a singular multi-electrode catheter
US20240156524A1 (en) * 2022-11-11 2024-05-16 Biosense Webster (Israel) Ltd. Electrode catheter with corrugated support structure
EP4397264A1 (en) * 2022-12-28 2024-07-10 Biosense Webster (Israel) Ltd. Electrode arrangement for planar catheter end effector
EP4393426A2 (en) 2022-12-29 2024-07-03 Biosense Webster (Israel) Ltd. Multi-electrode catheter with interlaced substrate
EP4566558A1 (en) * 2023-12-06 2025-06-11 Biosense Webster (Israel) Ltd. Reference electrode dedicated to catheter tissue proximity estimation

Also Published As

Publication number Publication date
US12232874B2 (en) 2025-02-25
US20210369339A1 (en) 2021-12-02

Similar Documents

Publication Publication Date Title
US20210369132A1 (en) Intraluminal reference electrode for cardiovascular treatment apparatus
EP3915501B1 (en) Intraluminal reference electrode for cardiovascular treatment apparatus
EP3603493B1 (en) Unipolar reference electrode for electrophysiology mapping catheter
JP7520967B2 (en) Catheter device with three pull wires
EP4048178B1 (en) Cardiac mapping catheter with square-spaced electrodes
US20230200895A1 (en) Catheter end effector with resilient frame and flexible interior
US20230190367A1 (en) Catheter end effector with laterally projecting body
US20240245359A1 (en) Catheter with insert-molded microelectrode
JP2005137908A (en) Catheter
EP4360577A1 (en) Irrigation tubing with regulated fluid emission
US20230149069A1 (en) Planar catheter with overlapping electrode pairs
EP4477171B1 (en) Intraluminal reference electrode for cardiovascular treatment apparatus
US20230310071A1 (en) Catheter with external magnetic coils
EP4342405B1 (en) Catheter shaft with multi-plane articulation and rotation
CN116889465A (en) Catheter with external magnetic coil
CN118203407A (en) Catheter with pull-ring coupling
JP2025059104A (en) Modular Steerable Sheaths and Catheters

Legal Events

Date Code Title Description
AS Assignment

Owner name: BIOSENSE WEBSTER (ISRAEL) LTD., ISRAEL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:VAN NIEKERK, PIETER EMMELIUS;MALINARIC, JAMIE LYNN;FUENTES-ORTEGA, CESAR;AND OTHERS;SIGNING DATES FROM 20200529 TO 20200921;REEL/FRAME:053862/0763

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION COUNTED, NOT YET MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED